[go: up one dir, main page]

CN1829485B - Method and apparatus for improving mitral valve function - Google Patents

Method and apparatus for improving mitral valve function Download PDF

Info

Publication number
CN1829485B
CN1829485B CN2004800215258A CN200480021525A CN1829485B CN 1829485 B CN1829485 B CN 1829485B CN 2004800215258 A CN2004800215258 A CN 2004800215258A CN 200480021525 A CN200480021525 A CN 200480021525A CN 1829485 B CN1829485 B CN 1829485B
Authority
CN
China
Prior art keywords
coronary sinus
roughly
central area
elongated body
mitral valve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2004800215258A
Other languages
Chinese (zh)
Other versions
CN1829485A (en
Inventor
J·M·罗尔克
J·R·利迪科尔特
D·C·泰勒
W·E·科恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viacor Inc
Original Assignee
Viacor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/446,470 external-priority patent/US7125420B2/en
Application filed by Viacor Inc filed Critical Viacor Inc
Publication of CN1829485A publication Critical patent/CN1829485A/en
Application granted granted Critical
Publication of CN1829485B publication Critical patent/CN1829485B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2451Inserts in the coronary sinus for correcting the valve shape

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Surgical Instruments (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)

Abstract

本文提供了一种用于减少二尖瓣回流的方法和装置。这种装置插入到病人二尖瓣的后部小叶附近的冠状窦中,所述装置适合于使二尖瓣后部小叶附近的至少一部分冠状窦的固有曲率变直,以便使后部环体向前移动,从而改善小叶接合并减少二尖瓣回流。

A method and device for reducing mitral valve regurgitation are provided herein. The device is inserted into the coronary sinus adjacent to the posterior leaflet of a patient's mitral valve and is adapted to straighten the intrinsic curvature of at least a portion of the coronary sinus adjacent to the posterior leaflet of the mitral valve to displace the posterior annulus anteriorly, thereby improving leaflet coaptation and reducing mitral valve regurgitation.

Description

用于改善二尖瓣功能的方法和装置Methods and devices for improving mitral valve function

未决在先专利申请的引用Citations of pending prior patent applications

本专利申请:This patent application:

(1)是Daniel C.Taylor等人于02/05/02提交的题为“用于改善二尖瓣功能的方法和装置”的未决在先美国专利申请No.10/068264(代理人档案号No.VIA-29)的部分继续申请;(1) is prior pending U.S. Patent Application No. 10/068264, filed 02/05/02 by Daniel C. Taylor et al., entitled "Method and Apparatus for Improving Mitral Valve Function" (Attorney Docket No. VIA-29) part of the continuation application;

(2)是John Liddicoat等人于03/29/02提交的题为“用于改善二尖瓣功能的方法和装置”的未决在先美国专利申请No.10/112354(代理人档案号No.VIA-19202122)的部分继续申请;(2) is prior pending U.S. Patent Application No. 10/112,354, filed 03/29/02 by John Liddicoat et al., entitled "Methods and Apparatus for Improving Mitral Valve Function," (Attorney Docket No. .VIA-19202122) part of the continuation application;

(3)是Daniel C.Taylor等人于08/14/02提交的题为“用于改善二尖瓣功能的方法和装置”的未决在先美国专利申请No.10/218649(代理人档案号No.VIA-23)的部分继续申请;(3) is prior pending U.S. Patent Application No. 10/218,649, filed 08/14/02 by Daniel C. Taylor et al., entitled "Methods and Apparatus for Improving Mitral Valve Function" (Attorney Docket No. VIA-23) part of the continuation application;

(4)是William E.Cohn等人于10/25/02提交的题为“用于改善二尖瓣功能的方法和装置”的未决在先美国专利申请No.10/280401(代理人档案号No.VIA-30)的部分继续申请;(4) is prior pending U.S. Patent Application No. 10/280401, filed 10/25/02 by William E. Cohn et al., entitled "Methods and Apparatus for Improving Mitral Valve Function" (Attorney Docket No. VIA-30) part of the continuation application;

(5)是Daniel C.Taylor等人于01/14/03提交的题为“用于减少二尖瓣回流的方法和装置”的未决在先美国专利申请No.10/342034(代理人档案号No.VIA-31)的部分继续申请;和(5) is prior pending U.S. Patent Application No. 10/342034, filed 01/14/03 by Daniel C. Taylor et al., entitled "Methods and Apparatus for Reducing Mitral Valve Regurgitation" (Attorney Docket No. VIA-31) part continuation application; and

(6)要求享有William E.Cohn等人于06/26/02提交的题为“用于改善二尖瓣功能的方法和装置”的未决在先美国专利申请(代理人档案号No.VIA-34 PROV)No.60/391790的权益。(6) Claiming Priority to Prior U.S. Patent Application, filed 06/26/02 by William E. Cohn et al., entitled "Method and Apparatus for Improving Mitral Valve Function" (Attorney Docket No. VIA -34 PROV) Interest in No. 60/391790.

上述六项专利申请通过引用结合于本文中。The above six patent applications are incorporated herein by reference.

发明领域field of invention

本发明大体上涉及外科方法和装置,更具体地涉及用于改善二尖瓣功能的外科方法和装置。The present invention relates generally to surgical methods and devices, and more particularly to surgical methods and devices for improving mitral valve function.

发明背景Background of the invention

二尖瓣修复是医治所有病原性二尖瓣回流的手术选择。利用当前的外科技术,可以修复70%到95%之间的回流二尖瓣。目前已经很好地证明了二尖瓣修复比二尖瓣更换更具优势。这些优势包括能更好地保护心脏功能,并减少与抗凝剂相关的出血、血栓栓塞和心内膜炎的风险。Mitral valve repair is the surgical option for the treatment of all pathogenic mitral regurgitation. With current surgical techniques, between 70% and 95% of regurgitant mitral valves can be repaired. The advantages of mitral valve repair over mitral valve replacement are well documented. These advantages include better preservation of cardiac function and reduced risk of bleeding, thromboembolism, and endocarditis associated with anticoagulants.

在当前的实践中,二尖瓣手术需要进行极具侵害性的处理,其包括切开胸壁、心肺旁路、心肺停搏以及切开心脏本身,以便能够接触到二尖瓣。这种手术与高发病率和死亡率联系在一起。由于与这种手术相关的风险,许多身体很弱的病人无法享受到二尖瓣回流的外科医治的潜在好处。另外,无法在早期对具有中度症状的二尖瓣回流病人进行干预,并且只能在心脏的官能不良发展到一定程度之后才能进行外科医治。In current practice, mitral valve surgery requires extremely invasive procedures that include incision of the chest wall, cardiopulmonary bypass, cardiopulmonary arrest, and incision of the heart itself to gain access to the mitral valve. This surgery is associated with high morbidity and mortality. Because of the risks associated with this procedure, many frail patients do not enjoy the potential benefits of surgical management of mitral regurgitation. In addition, patients with mitral regurgitation with moderate symptoms cannot be intervened at an early stage, and surgical treatment can only be performed after the development of cardiac dysfunction to a certain extent.

二尖瓣回流通常发生在心衰病人身上,并且是这些病人的发病率和死亡率的重要原因。在心衰的病人身上发生二尖瓣回流是由左心室、乳头肌和二尖瓣环体的几何构型变化造成的。这些几何构型的变化导致二尖瓣小叶在心脏收缩时不能完全接合。在这种情况下,只通过缝线或通过缝线与支撑环的组合来使二尖瓣环体形成褶皱,便可医治二尖瓣回流,从而减少扩张环体的圆周,并且恢复二尖瓣环体的原始几何构型。Mitral regurgitation commonly occurs in patients with heart failure and is an important cause of morbidity and mortality in these patients. Mitral regurgitation in patients with heart failure is caused by changes in the geometry of the left ventricle, papillary muscle, and mitral annulus. These geometrical changes cause the mitral valve leaflets to fail to fully coapt during systole. In such cases, mitral regurgitation can be treated by crimping the mitral annulus with sutures alone or with a combination of sutures and support rings, thereby reducing the circumference of the dilated annulus and restoring the mitral valve The original geometry of the torus.

更具体地说,目前用于二尖瓣修复的外科实践通常要求通过外科手术打开左心房,然后将缝线或更普遍地将缝线与支撑环的组合固定在环体的内表面上,从而减小二尖瓣环体的半径;这种结构用于以荷包口缝合的方式将环体系紧至较小的半径,从而通过改善小叶的接合而减少二尖瓣回流。More specifically, current surgical practice for mitral valve repair typically requires the left atrium to be surgically opened and sutures, or more generally a combination of sutures and support rings, to be secured to the interior surface of the annulus, thereby Reduces the radius of the mitral annulus; this configuration is used to tighten the annulus to a smaller radius with a purse-string suture, thereby reducing mitral regurgitation by improving leaflet coaptation.

二尖瓣的这种修复方法通常称为“瓣环成形术”,其有效地减少了心衰病人的二尖瓣回流。这又缓解了心衰症状,改善了生命质量并提高了寿命。然而遗憾的是,二尖瓣手术的侵害性和所伴随的风险导致大多数心衰病人只有少数可进行外科手术。因此,可提高小叶接合性并因此减少心衰病人中的二尖瓣回流的更少侵害性的方法可以使这种疗法适用于绝大多数病人。This repair of the mitral valve is commonly referred to as "annuloplasty" and is effective in reducing mitral regurgitation in heart failure patients. This in turn alleviates heart failure symptoms, improves quality of life and increases longevity. Unfortunately, however, the invasiveness of mitral valve surgery and the associated risks result in only a minority of most heart failure patients undergoing surgery. Thus, a less invasive approach to improve leaflet coaptation and thus reduce mitral regurgitation in heart failure patients could make this therapy suitable for the vast majority of patients.

二尖瓣回流还发生在约20%的身患急性心肌梗塞的病人身上。另外,在急性心肌梗塞的复原中,在约10%的发展成严重血液动力不稳定的病人中,二尖瓣回流是心原性休克的主要原因。患有二尖瓣回流和心原性休克的病人具有约50%的医院死亡率。消除这些病人中的二尖瓣回流极有好处。然而遗憾的是,患有严重二尖瓣回流并有急性心肌梗塞作为并发症的病人是特别高危的外科手术对象,因而不是传统瓣环成形术的良好手术对象。因此,在这些极其病弱的病人身上实现二尖瓣回流的暂时性减少或消除的无创式方法可为其提供从心肌梗塞或其它严重威胁生命的病症中康复的时间,并使其成为更佳的医疗、干预疗法或外科疗法的手术对象。Mitral regurgitation also occurs in approximately 20% of patients with acute myocardial infarction. Additionally, in recovery from acute myocardial infarction, mitral regurgitation is the major cause of cardiogenic shock in approximately 10% of patients who develop severe hemodynamic instability. Patients with mitral regurgitation and cardiogenic shock have an approximately 50% hospital mortality rate. Elimination of mitral regurgitation in these patients would be of great benefit. Unfortunately, however, patients with severe mitral regurgitation with acute myocardial infarction as a complication are particularly high-risk surgical candidates and are therefore not good candidates for conventional annuloplasty. Therefore, a non-invasive approach to temporarily reduce or eliminate mitral regurgitation in these extremely sick patients could provide them time to recover from a myocardial infarction or other serious life-threatening condition and make them a better patient. Surgical object for medical, interventional therapy or surgical therapy.

发明概要Summary of the invention

因此,本发明的一个目的是提供一种用于减少二尖瓣回流的改善的方法和装置。It is therefore an object of the present invention to provide an improved method and apparatus for reducing mitral valve regurgitation.

本发明的另一目的是提供一种用于减少二尖瓣回流的无创式方法和装置。Another object of the present invention is to provide a non-invasive method and device for reducing mitral valve regurgitation.

本发明的另一目的是提供一种用于减少二尖瓣回流的方法和装置,它们可以永久性地(例如用于心衰病人)或临时性地(例如用于患有二尖瓣回流和急性心肌梗塞的病人)配置使用。Another object of the present invention is to provide a method and device for reducing mitral valve regurgitation, which can be permanently (such as for heart failure patients) or temporarily (such as for patients with mitral valve regurgitation and patients with acute myocardial infarction).

通过本发明可实现这些及其它的目的,其包含一种用于减少二尖瓣回流的改善的方法和装置。These and other objects are achieved by the present invention, which includes an improved method and apparatus for reducing mitral valve regurgitation.

在本发明的一种形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In one form of the invention there is provided a method for reducing mitral valve regurgitation comprising:

将装置插入到病人二尖瓣的后部小叶附近的冠状窦中,该装置适合于使二尖瓣后部小叶附近的至少一部分冠状窦的固有曲率变直,以便使后部环体向前移动,从而改善小叶接合。Insertion of a device into the coronary sinus near the posterior leaflet of the patient's mitral valve, the device being adapted to straighten at least a portion of the inherent curvature of the coronary sinus near the posterior leaflet of the mitral valve in order to move the posterior annulus anteriorly , thereby improving leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将装置插入到病人二尖瓣的后部小叶附近的冠状窦中,该装置适合于使二尖瓣后部小叶附近的至少一部分冠状窦向前移动,以便使后部环体向前移动,从而改善小叶接合。inserting a device into the coronary sinus near the posterior leaflet of the patient's mitral valve, the device being adapted to move forward at least a portion of the coronary sinus near the posterior leaflet of the mitral valve to move the posterior annulus forward, thereby Improved leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将装置插入到病人二尖瓣的后部小叶附近的冠状窦中,该装置适合于减小二尖瓣后部小叶附近的至少一部分冠状窦的固有曲率的度数,以便使后部环体向前移动,从而改善小叶接合。inserting into the patient's coronary sinus adjacent to the posterior leaflet of the mitral valve a device adapted to reduce the degree of inherent curvature of at least a portion of the coronary sinus adjacent to the posterior leaflet of the mitral valve so as to anteriorly forward the posterior annulus movement, thereby improving leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将装置插入到病人二尖瓣的后部小叶附近的冠状窦中,该装置适合于增加二尖瓣后部小叶附近的至少一部分冠状窦的固有曲率半径,以便使后部环体向前移动,从而改善小叶接合。inserting into the coronary sinus near the posterior leaflet of the patient's mitral valve a device adapted to increase the intrinsic radius of curvature of at least a portion of the coronary sinus near the posterior leaflet of the mitral valve to move the posterior annulus anteriorly, Thereby improving leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将装置插入到病人二尖瓣的后部小叶附近的冠状窦中,该装置具有远端、近端和中间部分,该装置构造成当装置定位在二尖瓣的后部小叶附近的冠状窦中时,远端和近端将对冠状窦的壁施加向后的作用力,而中间部分将对冠状窦的壁施加向前的作用力,以便使后部环体向前移动,从而改善小叶接合。Inserting a device into the coronary sinus near the posterior leaflet of a patient's mitral valve, the device having a distal end, a proximal end, and a medial portion, the device configured to be positioned in the coronary sinus near the posterior leaflet of the mitral valve , the distal and proximal portions will exert a posterior force on the wall of the coronary sinus, while the medial portion will exert an anterior force on the wall of the coronary sinus in order to move the posterior annulus forward, thereby improving leaflet coaptation .

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将大致平直的细长本体插入到病人二尖瓣的后部小叶附近的冠状窦中,该大致平直的细长本体的长度相对于二尖瓣后部小叶附近的冠状窦的固有曲率来定制尺寸,使得当该大致平直的细长本体定位在冠状窦中时,其将导致至少一部分冠状窦在二尖瓣的后部小叶附近呈现出大致平直的结构,以便增加二尖瓣环体的曲率半径,从而改善小叶接合。A generally flat, elongated body having a length relative to the inherent curvature of the coronary sinus near the posterior leaflet of the mitral valve is inserted into the patient's coronary sinus near the posterior leaflet of the mitral valve. Dimensioned such that when the generally flat elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a generally flat configuration adjacent the posterior leaflet of the mitral valve, so as to increase the mitral annulus The radius of curvature of the body improves leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将大致刚性的细长本体插入到病人二尖瓣的后部小叶附近的冠状窦中,该大致刚性的细长本体相对于二尖瓣的后部小叶附近的冠状窦的固有曲率来设置,使得当该大致刚性的细长本体定位在冠状窦中时,其将导致至少一部分冠状窦在二尖瓣的后部小叶附近呈现出不同的结构,以便使后部环体向前移动,从而改善小叶接合。inserting a substantially rigid elongated body into the coronary sinus near the posterior leaflet of the patient's mitral valve, the substantially rigid elongated body positioned relative to the inherent curvature of the coronary sinus near the posterior leaflet of the mitral valve such that This generally rigid elongated body, when positioned in the coronary sinus, will cause at least a portion of the coronary sinus to assume a different configuration near the posterior leaflet of the mitral valve in order to move the posterior annulus anteriorly, improving the leaflet join.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将大致平直且大致刚性的细长本体插入到病人二尖瓣的后部小叶附近的冠状窦中,该大致平直且大致刚性的细长本体的长度相对于二尖瓣的后部小叶附近的冠状窦的固有曲率来定制尺寸,使得当该大致平直且大致刚性的细长本体定位在冠状窦中时,其将导致至少一部分冠状窦在二尖瓣的后部小叶附近呈现出大致平直的结构,以便增加二尖瓣环体的曲率半径,从而改善小叶接合。inserting a generally flat and generally rigid elongated body into the coronary sinus near the posterior leaflet of the patient's mitral valve, the length of the generally flat and generally rigid elongated body relative to the vicinity of the posterior leaflet of the mitral valve The inherent curvature of the coronary sinus is sized so that when the generally flat and generally rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to appear generally flat near the posterior leaflet of the mitral valve. Straight configuration in order to increase the radius of curvature of the mitral annulus, thereby improving leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的装置,其包括:In another form of the invention, there is provided an apparatus for reducing mitral valve regurgitation comprising:

具有远端、近端和中间部分的本体,该本体构造成当本体定位在二尖瓣的后部小叶附近的冠状窦中时,远端和近端将对冠状窦的壁施加向后的作用力,而中间部分将对冠状窦的壁施加向前的作用力,以便向前移动二尖瓣的后部环体,从而改善小叶接合。a body having a distal end, a proximal end, and an intermediate portion, the body being configured such that when the body is positioned in the coronary sinus near the posterior leaflet of the mitral valve, the distal and proximal ends will exert a posterior action on the wall of the coronary sinus force, while the medial portion will exert an anterior force on the wall of the coronary sinus in order to move the posterior annulus of the mitral valve anteriorly, thereby improving leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的装置,其包括:In another form of the invention, there is provided an apparatus for reducing mitral valve regurgitation comprising:

大致平直的细长本体,其适合于插入到病人二尖瓣的后部小叶附近的冠状窦中,该大致平直的细长本体的长度相对于二尖瓣的后部小叶附近的冠状窦的固有曲率来定制,使得当将该大致平直的细长本体定位在冠状窦中时,其将导致至少一部分冠状窦在二尖瓣的后部小叶附近呈现出大致平直的结构,以便增加二尖瓣环体的曲率半径,使其向前移动,从而改善小叶接合。a generally straight, elongated body adapted for insertion into the coronary sinus near the posterior leaflet of the patient's mitral valve, the length of the generally straight, elongated body being relative to the coronary sinus near the posterior leaflet of the mitral valve The inherent curvature of the mitral valve is tailored so that when the generally flat elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a generally flat configuration near the posterior leaflet of the mitral valve in order to increase The radius of curvature of the mitral annulus allows it to move anteriorly, thereby improving leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的装置,其包括:In another form of the invention, there is provided an apparatus for reducing mitral valve regurgitation comprising:

大致刚性的细长本体,其适合于插入到病人二尖瓣的后部小叶附近的冠状窦中,该大致刚性的细长本体相对于二尖瓣的后部小叶附近的冠状窦的固有曲率来构造,使得当该大致刚性的细长本体定位在冠状窦中时,其将导致至少一部分冠状窦在二尖瓣的后部小叶附近呈现出不同的结构,以便使后部环体向前移动,从而改善小叶接合。a substantially rigid elongated body adapted for insertion into the coronary sinus near the posterior leaflet of the patient's mitral valve, the substantially rigid elongated body being relatively rigid with respect to the inherent curvature of the coronary sinus near the posterior leaflet of the mitral valve configured such that when the substantially rigid elongated body is positioned in the coronary sinus it will cause at least a portion of the coronary sinus to assume a different configuration adjacent the posterior leaflet of the mitral valve in order to move the posterior annulus anteriorly, Thereby improving leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的装置,其包括:In another form of the invention, there is provided an apparatus for reducing mitral valve regurgitation comprising:

大致平直且大致刚性的细长本体,其适合于插入到病人二尖瓣的后部小叶附近的冠状窦中,该大致平直且大致刚性的细长本体的长度相对于二尖瓣的后部小叶附近的冠状窦的固有曲率来定制,使得当该大致平直且大致刚性的细长本体定位在冠状窦中时,其将导致至少一部分冠状窦在二尖瓣的后部小叶附近呈现出大致平直的结构,以便增加二尖瓣环体的曲率半径,使其向前移动,从而改善小叶接合。a generally straight and generally rigid elongated body adapted for insertion into the coronary sinus near the posterior leaflet of the patient's mitral valve, the length of the generally straight and generally rigid elongated body being relative to the posterior leaflet of the mitral valve The inherent curvature of the coronary sinus near the posterior leaflets of the mitral valve is tailored so that when the generally flat and generally rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to appear near the posterior leaflet of the mitral valve. A generally flat configuration in order to increase the radius of curvature of the mitral annulus, allowing it to move anteriorly and thereby improve leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将装置插入到病人二尖瓣的后部小叶附近的冠状窦中,该装置适合于使二尖瓣后部小叶附近的至少一部分冠状窦的固有曲率变直,以便使后部环体向前移动,从而改善小叶接合;Insertion of a device into the coronary sinus near the posterior leaflet of the patient's mitral valve, the device being adapted to straighten at least a portion of the inherent curvature of the coronary sinus near the posterior leaflet of the mitral valve in order to move the posterior annulus anteriorly , thereby improving leaflet coaptation;

该装置包括细长本体,在将细长本体插入到冠状窦中之前,其在无应力状态下具有比冠状窦的曲率度数更小的曲率度数,并且该装置的刚性高于处在装置和二尖瓣之间的解剖组织,使得装置在冠状窦中的布置将使后部环体向前移动,并且改善小叶接合。The device includes an elongated body having a degree of curvature less than that of the coronary sinus in an unstressed state prior to insertion of the elongated body into the coronary sinus, and the device is more rigid than when the device and the two The anatomy between the cusps such that placement of the device in the coronary sinus will move the posterior annulus anteriorly and improve leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将装置插入到病人二尖瓣的后部小叶附近的冠状窦中,该装置适合于使二尖瓣后部小叶附近的至少一部分冠状窦向前移动,以便使后部环体向前移动,从而改善小叶接合;inserting a device into the coronary sinus near the posterior leaflet of the patient's mitral valve, the device being adapted to move forward at least a portion of the coronary sinus near the posterior leaflet of the mitral valve to move the posterior annulus forward, thereby Improved leaflet coaptation;

该装置包括细长本体,在将细长本体插入到冠状窦中之前,其在无应力状态下具有比冠状窦更平直的结构,并且该装置的刚性高于处在装置和二尖瓣之间的解剖组织,使得装置在冠状窦中的布置将使后部环体向前移动,并且改善小叶接合。The device comprises an elongated body having a straighter structure than the coronary sinus in an unstressed state prior to insertion of the elongated body into the coronary sinus, and the device is more rigid than the The tissue is dissected such that placement of the device in the coronary sinus will move the posterior annulus anteriorly and improve leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将装置插入到病人二尖瓣的后部小叶附近的冠状窦中,该装置适合于减小二尖瓣后部小叶附近的至少一部分冠状窦的固有曲率度数,以便使后部环体向前移动,从而改善小叶接合;该装置包括在无应力状态下具有相对较平直结构的细长本体,并且该装置的刚性高于处在装置和二尖瓣之间的解剖组织,使得装置在冠状窦中的布置将使后部环体向前移动,并且改善小叶接合。inserting into the coronary sinus near the posterior leaflet of the patient's mitral valve a device adapted to reduce the degree of inherent curvature of at least a portion of the coronary sinus near the posterior leaflet of the mitral valve in order to move the posterior annulus anteriorly , thereby improving leaflet coaptation; the device includes an elongated body with a relatively straight configuration in the unstressed state, and the device is more rigid than the anatomy between the device and the mitral valve, allowing the device to be positioned in the coronary sinus The placement in will move the posterior annulus forward and improve leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将装置插入到病人二尖瓣的后部小叶附近的冠状窦中,该装置适合于增大二尖瓣后部小叶附近的至少一部分冠状窦的固有曲率半径,以便使后部环体向前移动,从而改善小叶接合;inserting into the coronary sinus near the posterior leaflet of the patient's mitral valve a device adapted to increase the intrinsic radius of curvature of at least a portion of the coronary sinus near the posterior leaflet of the mitral valve in order to move the posterior annulus anteriorly , thereby improving leaflet coaptation;

该装置包括在无应力状态下具有相对较平直结构的细长本体,并且该装置的刚性高于处在装置和二尖瓣之间的解剖组织,使得装置在冠状窦中的布置将使后部环体向前移动,并且改善小叶接合。The device includes an elongated body with a relatively straight configuration in the unstressed state, and the device is more rigid than the anatomy between the device and the mitral valve, so that placement of the device in the coronary sinus will The annulus moves forward and improves leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将装置插入到位于病人二尖瓣的后部小叶附近的冠状窦中,装置具有远端、近端和中间部分,该装置构造成当其定位在二尖瓣后部小叶附近的冠状窦中时,远端和近端将对冠状窦的壁施加向后的作用力,而中间部分将对冠状窦的壁施加向前的作用力,以便使后部环体向前移动,从而改善小叶接合;inserting a device into the coronary sinus near the posterior leaflet of a patient's mitral valve, the device having a distal end, a proximal end and an intermediate portion, the device being configured to be positioned in the coronary sinus near the posterior leaflet of the mitral valve , the distal and proximal portions will exert a posterior force on the wall of the coronary sinus, while the medial portion will exert an anterior force on the wall of the coronary sinus in order to move the posterior annulus anteriorly, thereby improving leaflet coaptation;

该装置包括在无应力状态下具有相对较平直结构的细长本体,并且该装置的刚性高于处在装置和二尖瓣之间的解剖组织,使得装置在冠状窦中的布置将使后部环体向前移动,并且改善小叶接合。The device includes an elongated body with a relatively straight configuration in the unstressed state, and the device is more rigid than the anatomy between the device and the mitral valve, so that placement of the device in the coronary sinus will The annulus moves forward and improves leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将大致平直的细长本体插入到病人二尖瓣后部小叶附近的冠状窦中,这种大致平直的细长本体的长度相对于二尖瓣后部小叶附近的冠状窦的固有曲率来定制,使得当该大致平直的细长本体定位在冠状窦中时,其将导致至少一部分冠状窦在二尖瓣的后部小叶附近呈现出大致平直的结构,以便增加二尖瓣环体的曲率半径,从而改善小叶接合;A generally flat, elongated body having a length relative to the inherent curvature of the coronary sinus near the posterior leaflet of the mitral valve is inserted into the patient's coronary sinus adjacent to the posterior leaflet of the mitral valve. Tailored so that when the generally flat elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a generally flat configuration adjacent the posterior leaflet of the mitral valve so as to increase the mitral annulus radius of curvature, thereby improving leaflet coaptation;

该大致平直的细长本体包括在无应力状态下具有大致平直结构的杆件,并且该装置的刚性高于处在装置和二尖瓣之间的解剖组织,使得装置在冠状窦中的布置将使后部环体向前移动,并且改善小叶接合。The generally flat elongated body includes a rod having a generally flat configuration in an unstressed state, and the device is more rigid than the anatomical tissue between the device and the mitral valve, allowing the device to remain in the coronary sinus The placement will move the posterior annulus forward and improve leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将大致刚性的细长本体插入到病人二尖瓣后部小叶附近的冠状窦中,该大致刚性的细长本体相对于二尖瓣后部小叶附近的冠状窦的固有曲率来构造,使得当这种大致刚性的细长本体定位在冠状窦中时,其将导致至少一部分冠状窦在二尖瓣的后部小叶附近呈现出不同的结构,以便使后部环体向前移动,从而改善小叶接合;A substantially rigid elongated body is inserted into the coronary sinus near the posterior leaflet of the mitral valve of the patient, the substantially rigid elongated body being configured relative to the inherent curvature of the coronary sinus near the posterior leaflet of the mitral valve such that when the A generally rigid elongated body that, when positioned in the coronary sinus, causes at least a portion of the coronary sinus to assume a different configuration near the posterior leaflets of the mitral valve in order to move the posterior annulus anteriorly, thereby improving leaflet coaptation ;

该大致刚性的细长本体包括在无应力状态下具有相对较平直结构的杆件,并且该装置的刚性高于处在装置和二尖瓣之间的解剖组织,使得装置在冠状窦中的布置将使后部环体向前移动,并且改善小叶接合。The generally rigid elongated body includes a rod with a relatively straight configuration in the unstressed state, and the device is more rigid than the anatomical tissue between the device and the mitral valve, allowing the device to remain in the coronary sinus. The placement will move the posterior annulus forward and improve leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将大致平直且大致刚性的细长本体插入到病人二尖瓣的后部小叶附近的冠状窦中,该大致平直且大致刚性的细长本体的长度相对于二尖瓣后部小叶附近的冠状窦的固有曲率来定制,使得当这种大致平直且大致刚性的细长本体定位在冠状窦中时,其将导致至少一部分冠状窦在二尖瓣的后部小叶附近呈现出大致平直的结构,以便增加二尖瓣环体的曲率半径,从而改善小叶接合;inserting a generally flat and generally rigid elongated body into the coronary sinus near the posterior leaflet of the patient's mitral valve, the length of the generally flat and generally rigid elongated body being relative to the length of the approximately posterior leaflet of the mitral valve The inherent curvature of the coronary sinus is tailored so that when this generally flat and generally rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to appear generally flat near the posterior leaflet of the mitral valve structure in order to increase the radius of curvature of the mitral annulus, thereby improving leaflet coaptation;

该大致平直且大致刚性的细长本体包括在无应力状态下具有大致平直结构的杆件,并且该装置的刚性高于处在装置和二尖瓣之间的解剖组织,使得装置在冠状窦中的布置将使后部环体向前移动,并且改善小叶接合。The generally flat and generally rigid elongated body includes a rod of generally flat configuration in an unstressed state, and the device is more rigid than the anatomical tissue between the device and the mitral valve, allowing the device to coronally Placement in the sinuses will move the posterior annulus anteriorly and improve leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的装置,其包括:In another form of the invention, there is provided an apparatus for reducing mitral valve regurgitation comprising:

具有远端、近端和中间部分的本体,该本体构造成当本体定位在二尖瓣后部小叶附近的冠状窦中时,远端和近端将对冠状窦的壁施加向后的作用力,并且中间部分将对冠状窦的壁施加向前的作用力,以便使二尖瓣的后部环体向前移动,从而改善小叶接合;a body having a distal end, a proximal end, and an intermediate portion configured such that when the body is positioned in the coronary sinus near the posterior leaflet of the mitral valve, the distal and proximal ends will exert a posterior force on the wall of the coronary sinus , and the medial portion will exert an anterior force on the wall of the coronary sinus in order to move the posterior annulus of the mitral valve anteriorly, thereby improving leaflet coaptation;

该本体包括在无应力状态下具有相对较平直结构的杆件,并且该装置的刚性高于处在装置和二尖瓣之间的解剖组织,使得装置在冠状窦中的布置将使后部环体向前移动,并且改善小叶接合。The body includes a rod with a relatively straight configuration in the unstressed state, and the device is more rigid than the anatomy between the device and the mitral valve, so that placement of the device in the coronary sinus will allow posterior The annulus moves forward and improves leaflet coaptation.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的装置,其包括:In another form of the invention, there is provided an apparatus for reducing mitral valve regurgitation comprising:

大致平直的细长本体,其适合于插入到病人二尖瓣后部小叶附近的冠状窦中,该大致平直的细长本体的长度相对于二尖瓣后部小叶附近的冠状窦的固有曲率来定制,使得当该大致平直的细长本体定位在冠状窦中时,其将导致至少一部分冠状窦在二尖瓣的后部小叶附近呈现出大致平直的结构,以便增加二尖瓣环体的曲率半径,使其向前移动,从而改善小叶接合;a generally straight, elongated body adapted for insertion into the coronary sinus near the posterior leaflet of the mitral valve in a patient, the length of the generally straight, elongated body being relative to the intrinsic coronary sinus near the posterior leaflet of the mitral valve The curvature is tailored so that when the generally flat elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a generally flat configuration near the posterior leaflet of the mitral valve in order to increase the The radius of curvature of the annulus, allowing it to move anteriorly, thereby improving leaflet coaptation;

该本体包括在无应力状态下具有大致平直结构的杆件,并且该装置的刚性高于处在装置和二尖瓣之间的解剖组织,使得装置在冠状窦中的布置将使后部环体向前移动,并且改善小叶接合。The body includes a stem with a generally flat configuration in an unstressed state, and the device is more rigid than the anatomy between the device and the mitral valve, so that placement of the device in the coronary sinus will cause the posterior annulus The body moves forward and leaflet coaptation improves.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的装置,其包括:In another form of the invention, there is provided an apparatus for reducing mitral valve regurgitation comprising:

大致刚性的细长本体,其适合于插入到病人二尖瓣后部小叶附近的冠状窦中,该大致刚性的细长本体相对于二尖瓣后部小叶附近的冠状窦的固有曲率来构造,使得当该大致刚性的细长本体定位在冠状窦中,其将导致至少一部分冠状窦在二尖瓣的后部小叶附近呈现出不同的结构,以便使后部环体向前移动,从而改善小叶接合;a substantially rigid elongated body adapted for insertion into the coronary sinus adjacent the posterior leaflet of the mitral valve in a patient, the substantially rigid elongated body configured relative to the inherent curvature of the coronary sinus adjacent the posterior leaflet of the mitral valve, Such that when the substantially rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to assume a different configuration in the vicinity of the posterior leaflet of the mitral valve in order to move the posterior annulus anteriorly, thereby improving the leaflet join;

该本体包括在无应力状态下具有大致平直结构的杆件,并且该装置的刚性高于处在装置和二尖瓣之间的解剖组织,使得装置在冠状窦中的布置将使后部环体向前移动,并且改善小叶接合。The body includes a stem with a generally flat configuration in an unstressed state, and the device is more rigid than the anatomy between the device and the mitral valve, so that placement of the device in the coronary sinus will cause the posterior annulus The body moves forward and leaflet coaptation improves.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的装置,其包括:In another form of the invention, there is provided an apparatus for reducing mitral valve regurgitation comprising:

大致平直且大致刚性的细长本体,其适合于插入到病人二尖瓣后部小叶附近的冠状窦中,该大致平直且大致刚性的细长本体的长度相对于二尖瓣后部小叶附近的冠状窦的固有曲率来定制,使得当这种大致平直且大致刚性的细长本体定位在冠状窦中时,其将导致至少一部分冠状窦在二尖瓣的后部小叶附近呈现出大致平直的结构,以便增加二尖瓣环体的曲率半径,使其向前移动,从而改善小叶接合;a generally straight and generally rigid elongated body adapted for insertion into the coronary sinus of a patient adjacent to the posterior leaflet of the mitral valve, the length of the generally straight and generally rigid elongated body being relative to the posterior leaflet of the mitral valve The inherent curvature of the nearby coronary sinus is tailored so that when this generally flat and generally rigid elongated body is positioned in the coronary sinus, it will cause at least a portion of the coronary sinus to appear approximately A flat configuration to increase the radius of curvature of the mitral annulus, allowing it to move anteriorly, thereby improving leaflet coaptation;

该本体包括在无应力状态下具有大致平直结构的杆件,并且该装置的刚性高于处在装置和二尖瓣之间的解剖组织,使得装置在冠状窦中的布置将使后部环体向前移动,并且改善小叶接合。The body includes a stem with a generally flat configuration in an unstressed state, and the device is more rigid than the anatomy between the device and the mitral valve, so that placement of the device in the coronary sinus will cause the posterior annulus The body moves forward and leaflet coaptation improves.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的方法,其包括:In another form of the invention, there is provided a method for reducing mitral valve regurgitation comprising:

将装置插入到病人二尖瓣后部小叶附近的冠状窦中,该装置适合于将二尖瓣后部小叶附近的至少一部分冠状窦的固有曲率进行转化,以便使后部环体向前移动,从而改善小叶接合,其中所述装置包括杆件以及与所述杆件相连的稳定支架。inserting a device into the patient's coronary sinus adjacent the posterior leaflet of the mitral valve, the device being adapted to transform at least a portion of the inherent curvature of the coronary sinus adjacent the posterior leaflet of the mitral valve to anteriorly move the posterior annulus, Leaflet engagement is thereby improved, wherein the device includes a rod and a stabilizing bracket connected to the rod.

在本发明的另一形式中,提供了一种用于减少二尖瓣回流的装置,其包括:In another form of the invention, there is provided an apparatus for reducing mitral valve regurgitation comprising:

细长本体,其适合于插入到病人二尖瓣后部小叶附近的冠状窦中,该装置适合于将二尖瓣后部小叶附近的至少一部分冠状窦的固有曲率进行转化,以便使后部环体向前移动,从而改善小叶接合,其中所述装置包括杆件以及与所述杆件相连的稳定支架。an elongated body adapted to be inserted into the coronary sinus adjacent to the posterior leaflet of the mitral valve in a patient, the device being adapted to transform the inherent curvature of at least a portion of the coronary sinus adjacent to the posterior leaflet of the mitral valve so that the posterior annulus The body moves forward to improve leaflet engagement, wherein the device includes a rod and a stabilizing bracket connected to the rod.

重要的是,可通过无创的方式永久性地或临时性地来实施本发明,以便减少二尖瓣回流。Importantly, the present invention can be implemented noninvasively, permanently or temporarily, in order to reduce mitral regurgitation.

附图简介Brief introduction to the drawings

通过以下结合附图来考虑的本发明优选实施例的详细描述,更完整地公开或披露了本发明的这些及其它目的和特征,在附图中采用相同的标号来表示相同的零部件,其中:These and other objects and features of the invention will be more fully disclosed or disclosed by the following detailed description of preferred embodiments of the invention considered in conjunction with the accompanying drawings, in which like reference numerals are used to designate like parts, wherein :

图1是人体血管系统的一部分的示意图;Figure 1 is a schematic diagram of a part of the human vascular system;

图2是人体心脏的一部分的示意图;Figure 2 is a schematic diagram of a part of a human heart;

图3是根据本发明来形成的优选系统的示意图;Figure 3 is a schematic diagram of a preferred system formed in accordance with the present invention;

图4-7是显示了采用图3所示系统来减少二尖瓣回流的一组图;4-7 are a set of graphs showing the reduction of mitral valve regurgitation using the system shown in FIG. 3;

图8显示了输送导管的一种备选形式;Figure 8 shows an alternative form of delivery catheter;

图9显示了柔性推杆的一种备选形式;Figure 9 shows an alternative form of flexible push rod;

图10显示了本发明的另一备选形式;Figure 10 shows another alternative form of the invention;

图11显示了本发明的另一备选形式;Figure 11 shows another alternative form of the invention;

图12-14显示了构成本发明的一种形式的细长本体的备选构造;Figures 12-14 show an alternative construction of an elongated body forming a form of the invention;

图15显示了根据本发明而形成的备选系统;Figure 15 shows an alternative system formed in accordance with the present invention;

图16显示了在配置使用系统的细长本体的期间图15所示系统的构造;Figure 16 shows the configuration of the system shown in Figure 15 during deployment of the elongated body of the system for use;

图17-19是细长本体的其它备选实施例的侧视图;17-19 are side views of other alternative embodiments of the elongate body;

图20是作用在本发明组件的操作部分上的作用力的示意图;Figure 20 is a schematic diagram of the forces acting on the operating portion of the assembly of the present invention;

图21是本发明的另一备选形式的示意图;Figure 21 is a schematic illustration of another alternative form of the invention;

图22是显示了配置在冠状窦中的图21所示结构的示意图;Figure 22 is a schematic diagram showing the structure shown in Figure 21 deployed in the coronary sinus;

图23是本发明的另一备选形式的示意图;Figure 23 is a schematic illustration of another alternative form of the invention;

图24是显示了配置在冠状窦中的图23所示结构的示意图;Figure 24 is a schematic diagram showing the structure shown in Figure 23 deployed in the coronary sinus;

图25是正常二尖瓣的示意图;Figure 25 is a schematic diagram of a normal mitral valve;

图26是回流二尖瓣的示意图;Figure 26 is a schematic diagram of a regurgitating mitral valve;

图27和28是显示了插入到冠状窦中的细长本体的示意图,其中该细长本体包括大致平直且大致刚性的中央部分;27 and 28 are schematic diagrams showing an elongated body inserted into a coronary sinus, wherein the elongated body includes a generally flat and generally rigid central portion;

图29和30是显示了插入到冠状窦中的另一细长本体的示意图,其中该细长本体包括弹性的中央部分和末端部分;29 and 30 are schematic diagrams showing another elongated body inserted into a coronary sinus, wherein the elongated body includes a resilient central portion and end portions;

图31和32是显示了插入到冠状窦中的另一细长本体的示意图,其中该细长本体具有沿其长度为可变的弹性。31 and 32 are schematic diagrams showing another elongated body inserted into the coronary sinus, wherein the elongated body has variable elasticity along its length.

图33是显示用于两种材料即镍钛合金和不锈钢的作用力变形曲线的示意图;Figure 33 is a schematic diagram showing force-deformation curves for two materials, Nitinol and stainless steel;

图34和35是细长本体的其它备选实施例的侧视图;34 and 35 are side views of other alternative embodiments of the elongated body;

图36是细长本体的另一备选实施例的示意图;Figure 36 is a schematic illustration of another alternative embodiment of an elongated body;

图37是显示了与稳定支架协同式接合的图35所示细长本体的示意性侧视图;Figure 37 is a schematic side view showing the elongated body of Figure 35 cooperatively engaged with a stabilizing bracket;

图38是配置在图37所示的稳定支架中的台阶的示意性剖视图;Figure 38 is a schematic cross-sectional view of a step configured in the stabilizing bracket shown in Figure 37;

图39是显示为处于冠状窦中的图37所示细长本体和稳定支架的示意图;39 is a schematic illustration of the elongated body and stabilizing scaffold of FIG. 37 shown in the coronary sinus;

图40是本发明的另一形式的示意图;Figure 40 is a schematic diagram of another form of the present invention;

图41是沿着图40中的线41-41的剖视图;Figure 41 is a cross-sectional view along line 41-41 in Figure 40;

图42是本发明的另一形式的示意图;Figure 42 is a schematic diagram of another form of the present invention;

图43是沿着图42中的线43-43的剖视图;Figure 43 is a cross-sectional view along line 43-43 in Figure 42;

图44是本发明的另一形式的示意图;Figure 44 is a schematic diagram of another form of the present invention;

图45是沿着图44中的线44-44的剖视图;Figure 45 is a cross-sectional view along line 44-44 in Figure 44;

图46是显示了配置在冠状窦中的图40-45所示构造的示意图;Figure 46 is a schematic diagram showing the configuration of Figures 40-45 deployed in the coronary sinus;

图47是本发明的另一形式的示意图;Figure 47 is a schematic diagram of another form of the present invention;

图48-51显示了用于将细长本体和稳定支架相结合的备选构造;Figures 48-51 show alternative configurations for combining an elongated body and a stabilizing bracket;

图52是图51所示的细长本体和稳定支架的组合的示意性透视图;Figure 52 is a schematic perspective view of the combination of the elongated body and stabilizing bracket shown in Figure 51;

图53是具有从中伸出的肋的细长本体的透视图;Figure 53 is a perspective view of an elongated body having ribs extending therefrom;

图54是图53所示细长本体和肋组件的顶平面视图;Figure 54 is a top plan view of the elongated body and rib assembly shown in Figure 53;

图55是细长本体和稳定支架的另一组合的示意性透视图;Figure 55 is a schematic perspective view of another combination of an elongate body and a stabilizing bracket;

图56是细长本体和稳定支架的组合的示意透视图,其中稳定支架的结构包括多个细长本体部件;Figure 56 is a schematic perspective view of the combination of an elongate body and a stabilizing bracket, wherein the structure of the stabilizing bracket includes a plurality of elongate body components;

图57是完全由稳定支架构件构成的细长本体的示意性侧视图;Figure 57 is a schematic side view of an elongated body constructed entirely of stabilizing frame members;

图58是显示了根据本发明而形成的细长本体和稳定支架的另一组合的示意性侧视图;Figure 58 is a schematic side view showing another combination of an elongated body and a stabilizing bracket formed in accordance with the present invention;

图59是显示了配置在病人冠状窦中的图57所示稳定支架的示意性侧视图;Fig. 59 is a schematic side view showing the stabilizing brace of Fig. 57 deployed in a patient's coronary sinus;

图60是显示了配置在病人冠状窦中的图57所示细长本体和稳定支架的组合的示意性侧视图;60 is a schematic side view showing the combination of the elongated body and stabilizing bracket of FIG. 57 deployed in the coronary sinus of a patient;

图61是显示了根据本发明而形成的细长本体和稳定支架的另一组合的示意性侧视图;Figure 61 is a schematic side view showing another combination of an elongated body and a stabilizing bracket formed in accordance with the present invention;

图62是显示了配置在病人冠状窦中的图60所示稳定支架的示意性侧视图;和Fig. 62 is a schematic side view showing the stabilizing brace of Fig. 60 deployed in a patient's coronary sinus; and

图63是显示了配置在病人冠状窦中的图60所示细长本体和稳定支架的组合的示意性侧视图。Fig. 63 is a schematic side view showing the combination of the elongate body and stabilizing bracket of Fig. 60 deployed in a patient's coronary sinus.

优选实施例的详细描述Detailed description of the preferred embodiment

冠状窦是人体心脏中的最大静脉。在其进入房室沟内的大部分过程中,冠状窦通常延伸到心脏左心房附近的约5到10厘米距离之处。重要的是,冠状窦的一部分长度、例如通常约为7-9厘米的一部分大致延伸到二尖瓣环体的后部周界的附近。本发明利用了这一事实。更具体地说,通过将一种新颖装置配置在二尖瓣后部小叶附近的冠状窦中,就可对二尖瓣后部小叶附近的冠状窦的固有曲率进行修改,以便使后部环体向前移动,以便改善小叶接合,从而减少二尖瓣回流。The coronary sinus is the largest vein in the human heart. During most of its course into the atrioventricular groove, the coronary sinus usually extends to a distance of about 5 to 10 centimeters near the left atrium of the heart. Importantly, a portion of the length of the coronary sinus, eg typically about 7-9 cm, extends approximately to the vicinity of the posterior perimeter of the mitral valve annulus. The present invention takes advantage of this fact. More specifically, by deploying a novel device in the coronary sinus near the posterior leaflet of the mitral valve, the intrinsic curvature of the coronary sinus near the posterior leaflet of the mitral valve can be modified so that the posterior annulus Move forward to improve leaflet coaptation, thereby reducing mitral regurgitation.

在本发明的一个优选实施例中,这种新颖装置包括具有大致平直结构的细长本体,该细长本体的长度制成为当细长本体定位在二尖瓣后部小叶附近的冠状窦中时,细长本体将导致至少一部分冠状窦在二尖瓣的后部小叶附近呈现出比较平直的结构,以便使后部环体向前移动,从而改善小叶接合。In a preferred embodiment of the invention, the novel device comprises an elongated body of generally flat configuration, the length of which is made such that when the elongated body is positioned in the coronary sinus near the posterior leaflet of the mitral valve, , the elongated body will cause at least a portion of the coronary sinus to appear relatively flat near the posterior leaflets of the mitral valve in order to move the posterior annulus anteriorly and thereby improve leaflet coaptation.

在本发明的一个优选实施例中,可以经皮式地接触到冠状窦,例如,可通过颈静脉或通过左锁骨下静脉而将细长本体引入病人的血管系统内,向下传送到上腔静脉,穿过右心房,之后进入冠状窦并设置在那里。或者,可通过在心脏上切开小切口或者经由某些其它切入到病人血管系统中的切口而将细长本体引入到冠状窦中。In a preferred embodiment of the invention, the coronary sinus is accessed percutaneously, for example, by introducing the elongated body into the patient's vasculature via the jugular vein or via the left subclavian vein, passing down the superior cavity The vein, which passes through the right atrium, then enters the coronary sinus and sets there. Alternatively, the elongated body may be introduced into the coronary sinus by making a small incision in the heart or through some other incision into the patient's vasculature.

在本发明的一个优选实施例中,通过以下方式将细长本体导入到冠状窦中的合适位置:(i)将其穿过预定位的导管,和/或(ii)在预定位的导线上传送细长本体,和/或(iii)以无引导的方式(例如在可操纵输送工具的末端上)将其传送到外科手术部位处。In a preferred embodiment of the present invention, the elongate body is introduced into place in the coronary sinus by (i) passing it through a pre-positioned catheter, and/or (ii) over a pre-positioned guidewire The elongated body is delivered, and/or (iii) delivered to the surgical site in an unguided manner (eg, on the tip of a steerable delivery tool).

一旦配置好,该新型装置便可永久性地留在合适位置(例如在身患与心衰有关的二尖瓣回流的病人的情况下),或者只是临时性地将这种新型装置留在合适位置(例如在身患与急性心肌梗塞有关的二尖瓣回流的病人的情况下)。Once deployed, the novel device can be left in place permanently (such as in the case of patients with mitral regurgitation associated with heart failure), or it can be left in place only temporarily. Location (eg in the case of a patient with mitral regurgitation associated with acute myocardial infarction).

可通过荧光透视法、超声波心动描记术、血管内超声波、血管显微镜、实时磁共振成像等来实现手术过程的可视化。可通过超声波心动描记术来确定手术过程的疗效,然而其它成像方式也是适用的。Visualization of the surgical procedure can be achieved by fluoroscopy, echocardiography, intravascular ultrasound, vascular microscopy, real-time magnetic resonance imaging, etc. The efficacy of the surgical procedure can be determined by echocardiography, although other imaging modalities are also suitable.

现在来看图1,其显示了病人心血管系统3的各方面。更具体地说,心血管系统3大体上包括心脏6、上腔静脉9、右锁骨下静脉12、左锁骨下静脉15、颈静脉18和下腔静脉21。上腔静脉9和下腔静脉21与心脏右心房24连通。冠状动脉口27通向冠状窦30。在冠状窦30的远端31(图2)处,脉管结构通向垂直下降的前室间静脉(AIV)32(参见图1和2)。对于本发明的目的而言,通常可以方便地认为用语“冠状窦”指在冠状动脉口27和AIV 32之间延伸的脉管结构。Turning now to FIG. 1 , various aspects of a patient's cardiovascular system 3 are shown. More specifically, cardiovascular system 3 generally includes heart 6 , superior vena cava 9 , right subclavian vein 12 , left subclavian vein 15 , jugular vein 18 and inferior vena cava 21 . The superior vena cava 9 and the inferior vena cava 21 communicate with the right atrium 24 of the heart. Coronary ostia 27 lead to coronary sinus 30 . At the distal end 31 (Fig. 2) of the coronary sinus 30, the vasculature opens into a vertically descending anterior interventricular vein (AIV) 32 (see Figs. 1 and 2). For purposes of the present invention, it is generally convenient to consider the term "coronary sinus" to refer to the vascular structure extending between the coronary ostium 27 and the AIV 32.

如图2所示,在冠状动脉口27和AIV 32之间,冠状窦30大致延伸到二尖瓣36的环体33的后部周界附近。二尖瓣36包括后部小叶39和前部小叶42。在二尖瓣产生回流的情况下,后部小叶39和前部小叶42在心脏收缩时通常将无法正确地接合,从而留下允许发生不利回流的中间间隙45。Between the coronary ostia 27 and the AIV 32, the coronary sinus 30 extends approximately to about the posterior perimeter of the annulus 33 of the mitral valve 36, as shown in FIG. The mitral valve 36 includes a posterior leaflet 39 and an anterior leaflet 42 . In the event of mitral valve regurgitation, the posterior leaflet 39 and anterior leaflet 42 will generally not coapt properly during systole, leaving an intermediate gap 45 that allows adverse regurgitation to occur.

接着参见图3,图中显示了包括本发明一个优选实施例的系统100。更具体地说,系统100大体上包括导线103、输送导管106和推杆109。Referring next to FIG. 3, there is shown a system 100 including a preferred embodiment of the present invention. More specifically, system 100 generally includes guidewire 103 , delivery catheter 106 and pushrod 109 .

导线103包括具有远端115和近端118的柔性本体112。导线103的远端115优选包括弹性顶部121,例如当导线103穿过病人的血管系统时,其允许导线103的远端无创式地穿过脉管结构。Lead 103 includes a flexible body 112 having a distal end 115 and a proximal end 118 . The distal end 115 of the guidewire 103 preferably includes a resilient top 121 that allows the distal end of the guidewire 103 to be passed noninvasively through the vasculature, eg, when the guidewire 103 is passed through the patient's vasculature.

输送导管106包括具有远端127和近端130的柔性本体124,并且优选连接有可调阀133。中央腔管136从远端127延长到近端130。在某些情况下可以提供紧固机构,用于将输送导管106的远端127固定在脉管结构内。作为示例而非限制性意义,将可膨胀的气囊139定位在柔性本体124外部的周围,刚好靠近远端127,并且使膨胀腔管142在气囊139和膨胀接头145之间延伸。Delivery catheter 106 includes a flexible body 124 having a distal end 127 and a proximal end 130 , and is preferably connected to an adjustable valve 133 . Central lumen 136 extends from distal end 127 to proximal end 130 . In some cases a securing mechanism may be provided for securing the distal end 127 of the delivery catheter 106 within the vasculature. By way of example and not limitation, an inflatable balloon 139 is positioned around the exterior of flexible body 124 , just near distal end 127 , and inflation lumen 142 extends between balloon 139 and inflation joint 145 .

推杆109包括具有远端151和近端154的柔性本体148。在柔性本体148上靠近远端151之处形成了具有各种不同长度的大致平直且大致刚性的细长本体157。在细长本体157和近端154之间设有可动的近端加劲杆(或手柄)160,以便促进手工地夹住柔性本体148以实现推进或收回目的。Pushrod 109 includes a flexible body 148 having a distal end 151 and a proximal end 154 . Formed on flexible body 148 proximate distal end 151 is a generally straight and generally rigid elongated body 157 of various lengths. A movable proximal stiffener (or handle) 160 is provided between the elongate body 157 and the proximal end 154 to facilitate manual gripping of the flexible body 148 for advancement or retraction purposes.

系统100可如下所述地使用以减少二尖瓣回流。System 100 may be used to reduce mitral valve regurgitation as described below.

首先将导线103的远端115向下穿过病人的颈静脉18(或左锁骨下静脉15),下至上腔静脉9,穿过心脏的右心房24,之后沿冠状窦30延伸。参见图4。应当理解,随着柔性导线103向下传送至冠状窦30中,由于导线的柔性,导线将倾向于呈现出冠状窦的自然弯曲形状。当操纵导线103就位时,导线的不会引发创伤的弹性顶部121将有助于保证对脉管结构造成的创伤最小。The distal end 115 of the guide wire 103 is first passed down the patient's jugular vein 18 (or left subclavian vein 15 ), down to the superior vena cava 9 , through the right atrium 24 of the heart, and then along the coronary sinus 30 . See Figure 4. It will be appreciated that as the flexible guidewire 103 is passed down into the coronary sinus 30, due to the flexibility of the guidewire, the guidewire will tend to assume the natural curved shape of the coronary sinus. The non-traumatic resilient top 121 of the lead will help ensure minimal trauma to the vascular structure when the lead 103 is steered into position.

接着将输送导管106的远端127定位在导线103的近端118之上,并沿着导线向下传递,直到输送导管106的远端127定位在冠状窦30中。参见图5。还应当理解,随着柔性输送导管106向下传递到冠状窦中时,由于输送导管的柔性,导管将倾向于呈现出冠状窦的自然弯曲形状。The distal end 127 of the delivery catheter 106 is then positioned over the proximal end 118 of the guidewire 103 and passed down the guidewire until the distal end 127 of the delivery catheter 106 is positioned in the coronary sinus 30 . See Figure 5. It should also be understood that as the flexible delivery catheter 106 is passed down into the coronary sinus, due to the flexibility of the delivery catheter, the catheter will tend to assume the natural curved shape of the coronary sinus.

一旦将输送导管106定位在冠状窦中,就除去导线103。参见图6。在去除导线103之前或之后可使气囊139膨胀,以便将输送导管106的远端127固定在冠状窦30中。Once the delivery catheter 106 is positioned in the coronary sinus, the guide wire 103 is removed. See Figure 6. Balloon 139 may be inflated to secure distal end 127 of delivery catheter 106 in coronary sinus 30 before or after guidewire 103 is removed.

接着将推杆109向下传送至输送导管106的中央腔管136中。随着推杆的大致平直且大致刚性的细长本体157穿过输送导管106的中央腔管136时,该大致平直且大致刚性的细长本体157将迫使输送导管106在大致平直且大致刚性的细长本体157当前所处的位置处呈现出大致平直的结构(图7)。随着推杆109沿着输送导管106向下推动,气囊139将起作用,从而将输送导管106的远端127固定在冠状窦30中。The push rod 109 is then passed down into the central lumen 136 of the delivery catheter 106 . The generally straight and generally rigid elongated body 157 of the pushrod forces the delivery catheter 106 in a generally straight and generally rigid position as it passes through the central lumen 136 of the delivery catheter 106 . The generally rigid elongated body 157 presents a generally flat configuration in its current position (FIG. 7). As the push rod 109 is pushed down the delivery catheter 106 , the balloon 139 will act to secure the distal end 127 of the delivery catheter 106 in the coronary sinus 30 .

可根据需要利用近端手柄160来将推杆109沿输送导管106向下推动(图3),直到该大致平直且大致刚性的细长本体157定位在二尖瓣36的后部环体33附近。参见图7。在发生这种情况时,输送导管106中的大致平直且大致刚性的细长本体157的存在将导致至少一部分冠状窦30在这点上呈现出大致平直的结构,使得二尖瓣36的后部环体33被向前挤压。这将导致二尖瓣的后部小叶39也向前移动,从而改善二尖瓣的小叶接合,并因此减少(或完全消除)二尖瓣回流。关于这一点应当理解,后部环体可向前移动,从而实现或试图达到解剖学上可能的小叶-小叶接合或小叶-环体接合的程度(例如在左心室畸变而束缚住小叶的情况下)。在本文中使用用语“改善的小叶接合”和/或“增强的小叶接合”等来涵括这两类接合或目标接合。使用标准的可视化手段(如超声波心动描记术和/或荧光透视法)可调整该大致平直且大致刚性的细长本体157的确切位置,从而减少(或完全消除)二尖瓣36中的回流。The push rod 109 can be pushed down the delivery catheter 106 ( FIG. 3 ) using the proximal handle 160 as needed until the generally straight and generally rigid elongated body 157 is positioned in the posterior annulus 33 of the mitral valve 36. nearby. See Figure 7. When this occurs, the presence of the generally flat and generally rigid elongated body 157 in the delivery catheter 106 will cause at least a portion of the coronary sinus 30 to assume a generally flat configuration at this point such that the mitral valve 36 The rear ring body 33 is pressed forward. This will cause the posterior leaflets 39 of the mitral valve to also move forward, thereby improving the leaflet coaptation of the mitral valve and thus reducing (or completely eliminating) mitral valve regurgitation. It should be understood at this point that the posterior annulus can be moved forward to achieve or attempt to achieve anatomically possible leaflet-leaflet coaptation or leaflet-annulus coaptation (e.g. in the case of left ventricular distortion that binds the leaflets ). The terms "improved leaflet coaptation" and/or "enhanced leaflet coaptation" and the like are used herein to encompass both types of coaptation or target coaptation. The exact position of the generally flat and generally rigid elongated body 157 can be adjusted to reduce (or completely eliminate) regurgitation in the mitral valve 36 using standard visualization means such as echocardiography and/or fluoroscopy. .

在这方面应当理解,大致平直且大致刚性的细长本体157的尺寸优选加工成比位于冠状动脉口27和AIV 32之间的冠状窦的长度略小。然而在某些情况下,需要将大致平直且大致刚性的细长本体157的尺寸加工成使其延伸到冠状窦30之外并进入右心房24。It should be appreciated in this regard that the generally flat and generally rigid elongated body 157 is preferably dimensioned to be slightly less than the length of the coronary sinus located between the coronary ostia 27 and the AIV 32. In some instances, however, it may be desirable to dimension the generally flat and generally rigid elongated body 157 so that it extends beyond the coronary sinus 30 and into the right atrium 24 .

此外还应当理解,系统在配置期间为用户提供了一定程度的触觉反馈。更具体地说,当大致平直且大致刚性的细长本体157被推出右心房24而进入冠状窦30时,通常将遇到相当大的阻力;之后阻力将通常随着本体157移动穿过冠状窦而下降;并且之后随着推杆109的远端151(图3)和/或本体157的前末端接近冠状窦的远端31,阻力通常将再次显著增大。这样,当大致平直且大致刚性的细长本体157定位在冠状动脉口27和AIV 32之间的冠状窦中时,就存在某些触觉“有效点”,该触觉“有效点”有助于用户将大致平直且大致刚性的细长本体157正确地定位在冠状窦30中。It should also be appreciated that the system provides a degree of tactile feedback to the user during configuration. More specifically, considerable resistance will generally be encountered as the generally flat and generally rigid elongated body 157 is pushed out of the right atrium 24 into the coronary sinus 30; and then as the distal end 151 of the pushrod 109 (FIG. 3) and/or the anterior end of the body 157 approaches the distal end 31 of the coronary sinus, the resistance will typically increase significantly again. Thus, when the generally flat and generally rigid elongated body 157 is positioned in the coronary sinus between the coronary ostium 27 and the AIV 32, there are certain tactile "effective points" that facilitate The user properly positions the generally straight and generally rigid elongated body 157 in the coronary sinus 30 .

在手术过程中的此刻,例如通过关闭导管的可调阀133(图3)便可将大致平直且大致刚性的细长本体157锁定住,并且使气囊139放气。At this point during the procedure, the generally flat and generally rigid elongated body 157 is locked and the balloon 139 deflated, eg, by closing the catheter's adjustable valve 133 (Fig. 3).

系统100(无导线103,其已经被除去)保留在这个位置上,直到其不再需要时为止。在某些情况(例如在身患与急性心肌梗塞相关的二尖瓣回流的病人的情况)下,这可能意味着系统100将在此位置中保留几小时、几天或几星期的时间。在其它情况(例如在身患与心衰相关的二尖瓣回流的病人的情况)下,系统100基本上是永久性的。如果要去除系统100,则从输送导管106中取出推杆109,然后从病人身上取出输送导管106。System 100 (without wire 103, which has been removed) remains in this position until it is no longer needed. In some cases (eg, in the case of a patient suffering from mitral regurgitation associated with acute myocardial infarction), this may mean that the system 100 will remain in this position for hours, days or weeks. In other cases, such as in the case of a patient suffering from mitral regurgitation associated with heart failure, the system 100 is essentially permanent. If the system 100 is to be removed, the push rod 109 is removed from the delivery catheter 106, and the delivery catheter 106 is removed from the patient.

因此可以看到,利用本发明,大致平直且大致刚性的细长本体157大致通过压配合进入到二尖瓣后部小叶附近的冠状窦的通常弯曲的部分内。通过将大致平直且大致刚性的细长本体157的长度相对于病人解剖结构的固有曲率进行正确的尺寸加工,并且通过将大致平直且大致刚性的细长本体157正确地定位在病人的冠状窦中,该大致平直且大致刚性的细长本体将导致至少一部分冠状窦在二尖瓣36的后部小叶39附近呈现出大致平直的结构。这种作用又会使二尖瓣的后部环体向前移动,从而改善小叶接合,并因此减少二尖瓣回流。因此,通过将大致平直且大致刚性的细长本体157插入到二尖瓣36的后部小叶39附近的冠状窦30中,可对二尖瓣的环体33进行有效的操作,使其呈现出增大的半径曲率。It can thus be seen that, with the present invention, the generally flat and generally rigid elongated body 157 is generally press fit into the generally curved portion of the coronary sinus near the posterior leaflet of the mitral valve. By correctly sizing the length of the generally flat and generally rigid elongated body 157 relative to the inherent curvature of the patient's anatomy, and by properly positioning the generally flat and generally rigid elongated body 157 on the patient's coronal In the sinuses, this generally flat and generally rigid elongated body will cause at least a portion of the coronary sinus to assume a generally flat configuration near the posterior leaflet 39 of the mitral valve 36 . This action, in turn, moves the posterior annulus of the mitral valve forward, thereby improving leaflet coaptation and thereby reducing mitral regurgitation. Thus, by inserting the generally flat and generally rigid elongated body 157 into the coronary sinus 30 near the posterior leaflet 39 of the mitral valve 36, the annulus 33 of the mitral valve can be effectively manipulated to assume the Increased radius curvature.

如上所述,通过将大致平直且大致刚性的细长本体157的长度相对于病人解剖结构的固有曲率进行正确的尺寸加工,并且通过将大致平直且大致刚性的细长本体157正确地定位在病人的冠状窦中,该大致平直且大致刚性的细长本体157将导致至少一部分冠状窦在二尖瓣36的后部小叶39附近呈现出大致平直的结构,由此驱动二尖瓣的后部环体向前移动,从而改善小叶接合,并因此减少二尖瓣回流。为此,推杆109优选作为成套工具的一部分来提供,该成套工具具有多个不同的推杆109,每一推杆对应于不同尺寸的细长本体157,这样,医生可为特定的病人解剖结构选择和设置尺寸合适的细长本体157。此外,如果在设置时发现(例如通过超声波心动描记术和/或荧光透视法)需要不同尺寸的细长本体157,那么可用具有所需尺寸的细长本体157的第二推杆109来替换第一推杆109。By correctly sizing the length of the generally straight and generally rigid elongated body 157 relative to the inherent curvature of the patient's anatomy and by properly positioning the generally straight and generally rigid elongated body 157 In the patient's coronary sinus, the generally flat and generally rigid elongated body 157 will cause at least a portion of the coronary sinus to assume a generally flat configuration near the posterior leaflet 39 of the mitral valve 36, thereby driving the mitral valve The posterior annulus moves forward, improving leaflet coaptation and thus reducing mitral regurgitation. To this end, the push rod 109 is preferably provided as part of a kit having a plurality of different push rods 109, each corresponding to a different sized elongated body 157, so that the physician can adjust for a particular patient anatomy. Structural selection and placement of an appropriately sized elongated body 157 . Furthermore, if at setup it is found (e.g., by echocardiography and/or fluoroscopy) that a different sized elongated body 157 is desired, the second pushrod 109 can be replaced with a second pusher 109 having an elongated body 157 of the desired size. One putt 109.

在本发明的一种优选形式中,为了一开始就确定适用于特定的病人解剖结构的细长本体157的恰当长度,可以首先将诊断用推杆109插入到病人的冠状窦中;同样,为了确定细长本体157的优选尺寸,可将一系列不同尺寸的诊断用推杆109顺序地插入到病人的冠状窦中。之后,可将合适尺寸的治疗用推杆109插入到冠状窦中,以便改善小叶接合,从而减少二尖瓣回流。In a preferred form of the invention, in order to initially determine the proper length of the elongated body 157 for a particular patient anatomy, the diagnostic pushrod 109 may first be inserted into the patient's coronary sinus; Having determined the preferred dimensions of the elongated body 157, a series of different sized diagnostic pushrods 109 can be sequentially inserted into the patient's coronary sinus. Thereafter, an appropriately sized therapeutic pushrod 109 may be inserted into the coronary sinus to improve leaflet coaptation and thereby reduce mitral valve regurgitation.

此外,在将诊断用推杆109插入到病人的冠状窦中之前,医生可以对冠状窦的尺寸进行初步评估,从而确定诊断用推杆109的细长本体157的初始估计长度。这可在荧光透视法中利用具有不透射线标志的导线103、或者通过使用具有不透射线标志的输送导管106、或者将具有不透射线标志的另一装置(如柔性元件)插入到冠状窦中、或者利用本领域中的技术人员所知的其它方式来完成。利用不透射线标志,医生可对冠状窦的尺寸进行初步评估,以便确定诊断用推杆109的细长本体157的初始估计长度;之后根据需要交换诊断用推杆109,直到确定细长本体157的合适长度为止,此时用治疗用推杆109来替换该合适尺寸的诊断用推杆。Additionally, prior to inserting the diagnostic pushrod 109 into the patient's coronary sinus, the physician may perform an initial assessment of the size of the coronary sinus to determine an initial estimated length of the elongated body 157 of the diagnostic pushrod 109 . This can be done in fluoroscopy using a guide wire 103 with radiopaque markers, or by using a delivery catheter 106 with radiopaque markers, or inserting another device with radiopaque markers, such as a flexible element, into the coronary sinus or other methods known to those skilled in the art. Using the radiopaque landmarks, the physician can perform an initial assessment of the size of the coronary sinus in order to determine an initial estimated length of the elongated body 157 of the diagnostic pusher 109; the diagnostic pusher 109 can then be exchanged as needed until the elongated body 157 is determined At this time, the therapeutic push rod 109 is used to replace the diagnostic push rod of suitable size.

还已发现,通过将大致平直且大致刚性的细长本体157插入到二尖瓣的后部小叶附近的冠状窦中,还可以重塑(remodeling)病人的左心室,从而有助于缓解充血性心衰。It has also been found that by inserting the generally flat and generally rigid elongated body 157 into the coronary sinus near the posterior leaflet of the mitral valve, it is also possible to remodel the patient's left ventricle, thereby helping to relieve congestion Sexual heart failure.

尤其要注意的是,根据本发明,该大致平直且大致刚性的细长本体157的远端和近端会在冠状窦30的壁上施加向后的作用力(例如图7中箭头P所示),而该大致平直且大致刚性的细长本体157的中间部分会在冠状窦30的壁上施加向前的作用力(例如图7中箭头A所示)。Of particular note is that, in accordance with the present invention, the distal and proximal ends of the generally flat and generally rigid elongated body 157 exert a rearward force on the wall of the coronary sinus 30 (eg, indicated by arrow P in FIG. 7 ). ), and the middle portion of the generally flat and generally rigid elongated body 157 exerts a forward force on the wall of the coronary sinus 30 (eg, indicated by arrow A in FIG. 7 ).

在某些情况下,可利用标准病人护理方法如胶带、荷包口缝合线、缝皮钉等将输送导管106的近端130(图3)固定在病人的外皮上。在其它情况下,输送导管106的近端130可包括缝线套,从而可通过缝合将输送导管固定在病人的组织上。例如参见图8,图中显示了缝线套166连接在输送导管106的近端130上。如果需要的话,可在可调阀133的附近提供元件169,以便使柔性推杆109在不使用可调阀133(图3)的条件下快速传送至输送导管106。作为示例,元件169包括可将柔性推杆109固定在输送导管106上的可卷曲元件,例如利用缝线套166可将输送导管106固定在病人身上。如果需要的话,例如在永久性植入的情况下,可将组件的近端埋设在病人的皮肤之下。In some cases, the proximal end 130 (FIG. 3) of the delivery catheter 106 can be secured to the patient's skin using standard patient care methods such as tape, purse-string sutures, skin staples, and the like. In other cases, the proximal end 130 of the delivery catheter 106 may include a suture sleeve so that the delivery catheter may be secured to the patient's tissue by suturing. See, for example, FIG. 8 , which shows suture cover 166 attached to proximal end 130 of delivery catheter 106 . If desired, an element 169 may be provided adjacent to the adjustable valve 133 to allow rapid delivery of the flexible pushrod 109 to the delivery catheter 106 without the use of the adjustable valve 133 (FIG. 3). As an example, element 169 includes a crimpable element that can secure flexible pusher 109 to delivery catheter 106 , such as with suture cover 166 , to secure delivery catheter 106 to the patient. If desired, such as in the case of permanent implantation, the proximal end of the assembly can be buried under the patient's skin.

如上所述,在将推杆109推入到输送导管中之前,将输送导管106的远端锚固在冠状窦中是有帮助的。当大致平直且大致刚性的细长本体157在右心房内翻转并进入冠状窦中时,这种设置将使输送导管保持在合适位置。在未进行这种锚固时,推杆可能驱使输送导管下滑到下腔静脉21中。更具体地说,当大致平直且大致刚性的细长本体157遇到初始阻力而在冠状窦中翻转时,通过将输送导管106的远端固定在冠状窦30的壁上,便可使导管稳定下来而不会转向到下腔静脉21中。气囊139是实现这种锚固的一种方式。然而,还可以利用其它类型的紧固机构如弹簧夹、肋等来将输送导管106的远端127锚固在冠状窦30中的合适位置。As noted above, it is helpful to anchor the distal end of the delivery catheter 106 in the coronary sinus prior to advancing the pushrod 109 into the delivery catheter. This arrangement will hold the delivery catheter in place as the generally flat and generally rigid elongated body 157 is inverted within the right atrium and into the coronary sinus. In the absence of such anchoring, the push rod may drive the delivery catheter down into the inferior vena cava 21 . More specifically, by securing the distal end of the delivery catheter 106 to the wall of the coronary sinus 30 when the generally flat and generally rigid elongated body 157 overturns in the coronary sinus against initial resistance, the catheter Stabilize without turning into the inferior vena cava 21 . Balloon 139 is one way to achieve this anchoring. However, other types of fastening mechanisms, such as spring clips, ribs, etc., may also be utilized to anchor the distal end 127 of the delivery catheter 106 in place in the coronary sinus 30 .

如果需要,推杆109的远端151本身可设有末端锚固器,例如图9所示的末端锚固器172。推杆109上的这种末端锚固器有助于将大致平直且大致刚性的细长本体157保持在冠状窦30中的适当位置处。If desired, the distal end 151 of the push rod 109 may itself be provided with a tip anchor, such as the tip anchor 172 shown in FIG. 9 . Such end anchors on the pushrod 109 help to hold the generally flat and generally rigid elongated body 157 in place in the coronary sinus 30 .

在没有将输送导管106的远端锚固在冠状窦的壁上的条件下,也可以防止输送导管106向下转到下腔静脉21中。更具体地说,现在参见图10,图中显示了一种由比输送导管106的柔性本体124更刚硬的材料形成的支撑导管173。支撑导管173构造成当推杆109向下穿过输送导管106时,可使其远端174定位在冠状动脉口27中,之后其侧壁174A可将输送导管106支撑在下腔静脉21的附近,以便防止输送导管106向下转到下腔静脉21中。图10还显示了位于颈静脉18的入口处的插入导管174B。The delivery catheter 106 is also prevented from turning down into the inferior vena cava 21 without anchoring the distal end of the delivery catheter 106 on the wall of the coronary sinus. More specifically, referring now to FIG. 10 , a support catheter 173 formed of a more rigid material than the flexible body 124 of the delivery catheter 106 is shown. The support catheter 173 is configured to position its distal end 174 in the coronary ostia 27 when the pushrod 109 is passed down through the delivery catheter 106, after which its sidewall 174A supports the delivery catheter 106 in the vicinity of the inferior vena cava 21, In order to prevent the delivery catheter 106 from turning down into the inferior vena cava 21 . FIG. 10 also shows insertion catheter 174B at the entrance to jugular vein 18 .

在上面讨论的系统100中,推杆109描述成可通过输送导管106而推进到外科手术部位处,并在外科手术处保留在输送导管106中,并且当要取出推杆109时,可先取出推杆109,然后取出输送导管106。然而如果需要的话,一旦将推杆109配置在外科手术部位处,就可取出输送导管106,在外科手术部位只留下推杆109。例如参见图11。In the system 100 discussed above, the push rod 109 was described as being advanceable through the delivery catheter 106 to the surgical site, where it remained in the delivery catheter 106, and when the push rod 109 was to be removed, it could be removed first. Push rod 109, and then remove delivery catheter 106. However, once the pusher rod 109 is deployed at the surgical site, the delivery catheter 106 can be removed, leaving only the pusher rod 109 at the surgical site, if desired. See, for example, FIG. 11 .

还可将推杆109直接推进到外科手术部位,而不必通过导管进行传送;在这种情况下,推杆109可通过室间脉管结构自行前进,直到配置在冠状窦30中时为止。The push rod 109 can also be advanced directly to the surgical site without having to be delivered through a catheter; in this case, the push rod 109 can self-advance through the interventricular vasculature until deployed in the coronary sinus 30 .

如上所述,当推杆109推进到二尖瓣的后部环体附近的区域中时,大致平直且大致刚性的细长本体157将使冠状窦的固有结构变形,使其呈现出大致平直的结构。虽然这种作用可诱发所需的二尖瓣重塑,但是其也可能在冠状窦的壁上、尤其是在大致平直且大致刚性的细长本体157的远端和近端处引发极大的应力,在这些地方将产生应力集中(参见图7中的箭头P)。为此,可对该大致平直且大致刚性的细长本体157的构造进行修改,使这些应力能够更好地分布。As mentioned above, when the push rod 109 is advanced into the region near the posterior annulus of the mitral valve, the generally flat and generally rigid elongated body 157 will deform the intrinsic structure of the coronary sinus to assume a generally flat shape. straight structure. While this action may induce the desired mitral valve remodeling, it may also induce extreme pressure on the walls of the coronary sinus, particularly at the distal and proximal ends of the generally flat and generally rigid elongated body 157. Stress concentration will occur in these places (see arrow P in Figure 7). To this end, the configuration of the generally flat and generally rigid elongated body 157 can be modified to better distribute these stresses.

更具体地说,接下来参看图12,大致平直且大致刚性的细长本体157的远端和近端包括相对柔性的部分175,其有助于施加在冠状窦的壁上的应力更好地分布。作为附加和/或另选,应用于大致平直且大致刚性的细长本体157的远端和近端上的任何锥体可以是细长的,如图13中的标号178所示,从而使所施加的应力更好地分布在冠状窦的壁上。在本发明的一种优选形式中,现在参见图14,该大致平直且大致刚性的细长本体157包括具有相对细长锥体178的相对较长且相对柔性的部分175。如果需要的话,各个包括相对细长锥体178的相对较长且相对柔性的部分175可与细长本体157的大致平直且大致刚性的中间部分一样长,或者更长一些。More specifically, referring next to FIG. 12 , the distal and proximal ends of the generally flat and generally rigid elongated body 157 include relatively flexible portions 175 that contribute to better stress exerted on the walls of the coronary sinus. ground distribution. Additionally and/or alternatively, any tapers applied to the distal and proximal ends of the generally straight and generally rigid elongated body 157 may be elongated, as shown at 178 in FIG. The applied stress is better distributed on the walls of the coronary sinus. In a preferred form of the invention, referring now to FIG. 14 , the generally flat and generally rigid elongated body 157 includes a relatively long and relatively flexible portion 175 having a relatively elongated cone 178 . Each relatively long and relatively flexible portion 175 including a relatively elongated cone 178 may be as long as the generally straight and generally rigid mid-section of the elongated body 157, or longer, if desired.

接着来看图15,图中显示了包括本发明的另一优选实施例的系统181。更具体地说,系统181通常包括导线103、大致平直且大致刚性的细长本体184以及推压套管187。Turning next to Figure 15, there is shown a system 181 comprising another preferred embodiment of the present invention. More specifically, system 181 generally includes lead wire 103 , a generally straight and generally rigid elongated body 184 , and push sleeve 187 .

导线103如上文所述。The wire 103 is as described above.

以各种不同长度提供的大致平直且大致刚性的细长本体184包括远端188和近端190。中央腔管193在远端188和近端190之间延伸。中央腔管193可容纳导线103。The generally straight and generally rigid elongated body 184 , provided in various lengths, includes a distal end 188 and a proximal end 190 . Central lumen 193 extends between distal end 188 and proximal end 190 . Central lumen 193 may accommodate guidewire 103 .

推压套管187包括远端194和近端196。中央腔管199在远端194和近端196之间延伸。中央腔管199可容纳导线103。Push sleeve 187 includes a distal end 194 and a proximal end 196 . Central lumen 199 extends between distal end 194 and proximal end 196 . Central lumen 199 can accommodate guidewire 103 .

系统181以下述方式使用以便减少二尖瓣回流。System 181 is used in the following manner to reduce mitral valve regurgitation.

首先将导线103的远端115穿过病人的颈静脉18(或左锁骨下静脉15),向下至上腔静脉9,穿过心脏的右心房24,并沿冠状窦30延伸。应当理解,当柔性导线103穿过冠状窦30时,由于导线的柔性,导线将趋向于呈现出冠状窦的自然弯曲形状。导线的无创式弹性顶部121将有助于最大限度地减小随着导线前进到恰当位置时对脉管结构所造成的损伤。The distal end 115 of the lead 103 is first passed through the patient's jugular vein 18 (or left subclavian vein 15 ), down to the superior vena cava 9 , through the right atrium 24 of the heart, and along the coronary sinus 30 . It should be understood that when the flexible guidewire 103 is passed through the coronary sinus 30, due to the flexibility of the guidewire, the guidewire will tend to assume the naturally curved shape of the coronary sinus. The atraumatic elastic top 121 of the lead will help minimize damage to the vascular structure as the lead is advanced into place.

接下来将大致平直且大致刚性的细长本体184的远端188定位在导线103的近端118上,并沿导线向下传递一段较短距离。然后将推压套管187的远端194定位在导线103的近端118上,之后沿着导线向下推进推压套管187。随着推压套管187沿着导线推进,其远端194推挤位于其前方的大致平直且大致刚性的细长本体184。参见图16。The distal end 188 of the generally straight and generally rigid elongated body 184 is next positioned over the proximal end 118 of the lead 103 and passed down the lead a short distance. The distal end 194 of the push sleeve 187 is then positioned over the proximal end 118 of the guidewire 103, after which the push sleeve 187 is advanced down the guidewire. As the pusher sleeve 187 is advanced along the guidewire, its distal end 194 pushes against the generally straight and generally rigid elongated body 184 in front of it. See Figure 16.

随着将大致平直且大致刚性的细长本体184传递至冠状窦中,其将迫使冠状窦在大致平直且大致刚性的细长本体184当前所处的位置处呈现出大致平直的结构。可根据需要沿着导线向下推动推压套管187,直到大致平直且大致刚性的细长本体184定位于二尖瓣的后部环体附近时为止。当这种情况发生时,该大致平直且大致刚性的细长本体184在冠状窦中的存在将导致冠状窦在该点处呈现出大致平直的结构,从而使二尖瓣的后部环体受到向前压迫。这将导致二尖瓣的后部小叶也向前移动,从而改善小叶接合,并因此减少(或完全消除)二尖瓣回流。利用标准可视化手段(如超声波心动描记术和/或荧光透视法)可调整该大致平直且大致刚性的细长本体的确切位置,从而减少(或完全消除)二尖瓣中的回流。As the generally straight and generally rigid elongated body 184 is passed into the coronary sinus, it will force the coronary sinus to assume a generally flat configuration where the generally straight and generally rigid elongated body 184 currently resides . The push sleeve 187 can be pushed down the wire as needed until the generally straight and generally rigid elongated body 184 is positioned adjacent the posterior annulus of the mitral valve. When this occurs, the presence of the generally flat and generally rigid elongated body 184 in the coronary sinus will cause the coronary sinus to assume a generally flat configuration at this point, allowing the posterior annulus of the mitral valve to The body is pressed forward. This causes the posterior leaflets of the mitral valve to also move forward, thereby improving leaflet coaptation and thus reducing (or completely eliminating) mitral regurgitation. The exact position of the generally flat and generally rigid elongated body can be adjusted to reduce (or completely eliminate) regurgitation in the mitral valve using standard visualization means such as echocardiography and/or fluoroscopy.

如果需要的话,推压套管187可设有可释放的连接接口(例如抓紧器),从而使其可释放地对大致平直且大致刚性的细长本体184的近端190进行固定。这种特征将允许为了定位或取出的目的而将该大致平直且大致刚性的细长本体拉回到冠状窦中。If desired, the push sleeve 187 may be provided with a releasable connection interface (eg, a grasper) such that it releasably secures the proximal end 190 of the generally flat and generally rigid elongated body 184 . Such a feature would allow the generally flat and generally rigid elongated body to be pulled back into the coronary sinus for positioning or extraction purposes.

因此可以看到,根据本发明,大致平直且大致刚性的细长本体184基本上通过压配合进入到二尖瓣后部小叶附近的冠状窦的通常弯曲的部分内。通过相对于病人解剖结构的固有曲率来正确地加工大致平直且大致刚性的细长本体184的长度,并且通过将大致平直且大致刚性的细长本体184正确地定位在病人的冠状窦中,这种大致平直且大致刚性的细长本体184就将导致至少一部分冠状窦在二尖瓣36的后部小叶39附近呈现出大致平直的结构。这种作用又使二尖瓣的后部环体向前移动,从而改善小叶接合,并因此减少二尖瓣回流。这样,通过将大致平直且大致刚性的细长本体184插入到二尖瓣36的后部小叶39附近的冠状窦30中,可对二尖瓣的环体33进行有效的操作,使其呈现出增大的半径曲率。It can thus be seen that, in accordance with the present invention, the generally flat and generally rigid elongated body 184 is substantially press fit into the generally curved portion of the coronary sinus near the posterior leaflet of the mitral valve. By properly machining the length of the generally straight and generally rigid elongated body 184 with respect to the inherent curvature of the patient's anatomy and by properly positioning the generally straight and generally rigid elongated body 184 in the patient's coronary sinus This generally flat and generally rigid elongated body 184 will cause at least a portion of the coronary sinus to assume a generally flat configuration adjacent the posterior leaflet 39 of the mitral valve 36 . This action in turn moves the posterior annulus of the mitral valve forward, thereby improving leaflet coaptation and thereby reducing mitral regurgitation. Thus, by inserting the generally flat and generally rigid elongated body 184 into the coronary sinus 30 near the posterior leaflet 39 of the mitral valve 36, the annulus 33 of the mitral valve can be effectively manipulated to assume the Increased radius curvature.

如上所述,通过相对于病人解剖结构的固有曲率来正确地加工大致平直且大致刚性的细长本体184的长度,并且通过将大致平直且大致刚性的细长本体184正确地定位在病人的冠状窦中,这种大致平直且大致刚性的细长本体184就将导致至少一部分冠状窦在二尖瓣36的后部小叶39附近呈现出大致平直的结构,这又会驱使二尖瓣的后部环体向前移动,从而改善小叶接合,并因此减少二尖瓣回流。为此,该大致平直且大致刚性的细长本体184优选作为成套工具的一部分来提供,该成套工具包括多个不同的大致平直且大致刚性的细长本体184,它们均带有不同尺寸的细长本体184,这样,医生可为特定的病人解剖结构选择和配置尺寸合适的细长本体184。此外,如果在配置时发现(例如通过超声波心动描记术和/或荧光透视法)需要不同尺寸的细长本体184,那么可用具有所需尺寸的第二细长本体184来替换第一细长本体184,从而达到所需的治疗效果。As described above, the length of the generally straight and generally rigid elongated body 184 is properly machined with respect to the inherent curvature of the patient's anatomy, and by properly positioning the generally straight and generally rigid elongated body 184 on the patient's In the coronary sinus of the mitral valve 36, this generally flat and generally rigid elongated body 184 will cause at least a portion of the coronary sinus to assume a generally flat configuration near the posterior leaflet 39 of the mitral valve 36, which in turn will drive the mitral The posterior annulus of the valve is moved forward, improving leaflet coaptation and thus reducing mitral regurgitation. To this end, the generally straight and generally rigid elongated body 184 is preferably provided as part of a kit that includes a plurality of different generally straight and generally rigid elongated bodies 184, each with a different size In this way, the physician can select and configure the elongated body 184 of appropriate size for a specific patient anatomy. Additionally, if at configuration time it is found (e.g., by echocardiography and/or fluoroscopy) that a different sized elongated body 184 is desired, the first elongated body 184 can be replaced with a second elongated body 184 of the desired size. 184, so as to achieve the desired therapeutic effect.

在本发明的一种优选形式中,为了一开始便确定适用于特定的病人解剖结构的细长本体184的恰当长度,可以首先将诊断细长本体184插入到病人的冠状窦中;同样,为了确定治疗细长本体184的优选尺寸,可将一系列不同尺寸的诊断细长本体顺序地插入到病人的冠状窦中。之后,可将合适尺寸的治疗用细长本体184插入到冠状窦中,以便改善小叶接合,从而减少二尖瓣回流。In a preferred form of the invention, in order to initially determine the proper length of the elongated body 184 for a particular patient's anatomy, the diagnostic elongated body 184 may first be inserted into the patient's coronary sinus; Having determined the preferred size of the therapeutic elongated body 184, a series of different sized diagnostic elongated bodies can be sequentially inserted into the patient's coronary sinus. Thereafter, an appropriately sized therapeutic elongate body 184 may be inserted into the coronary sinus to improve leaflet coaptation and thereby reduce mitral valve regurgitation.

此外,在将诊断用细长本体184插入到病人的冠状窦中之前,医生可以对冠状窦的尺寸进行初步评估,从而确定诊断用细长本体184的初始估计长度。这可在荧光透视法中利用具有不透射线标志的导线103、或者将具有不透射线标志的另一装置(如柔性元件)插入到冠状窦中、或者利用本领域中的技术人员所知的其它方式来完成。利用不透射线的标志,医生可对冠状窦的尺寸进行初步评估,以便确定诊断用细长本体184的初始估计长度;之后根据需要交换诊断用细长本体184,直到确定诊断用细长本体184的合适长度为止,此时用治疗用细长本体184来替换该合适尺寸的诊断用细长本体184。Additionally, prior to inserting diagnostic elongated body 184 into the patient's coronary sinus, the physician may perform an initial assessment of the size of the coronary sinus to determine an initial estimated length of diagnostic elongated body 184 . This can be done in fluoroscopy using a guide wire 103 with radiopaque markers, or inserting another device with radiopaque markers (such as a flexible element) into the coronary sinus, or using other methods known to those skilled in the art. other ways to complete. Using the radiopaque landmarks, the physician can perform an initial assessment of the size of the coronary sinus in order to determine an initial estimated length of the diagnostic elongated body 184; thereafter, exchange the diagnostic elongated body 184 as needed until the diagnostic elongated body 184 is determined The appropriate length of the diagnostic elongated body 184 is replaced by the therapeutic elongated body 184 at this time.

同样如上所述,当该大致平直且大致刚性的细长本体184推进到二尖瓣后部环体附近的区域中时,该大致平直且大致刚性的细长本体184将使冠状窦的固有结构变形,使其呈现出大致平直的结构。虽然这种作用可诱发所需的二尖瓣重塑,但是其也可能在冠状窦的壁上、尤其是在大致平直且大致刚性的细长本体184的远端和近端处引发极大的应力,在这些地方将产生应力集中(参见图7中的箭头P)。为此,可对该大致平直且大致刚性的细长本体184的构造进行修改,使这些应力能够更好地分布。Also as described above, when the generally straight and generally rigid elongated body 184 is advanced into the region near the posterior annulus of the mitral valve, the generally straight and generally rigid elongated body 184 will allow the coronary sinus The intrinsic structure deforms so that it assumes a roughly flat structure. While this action may induce the desired mitral valve remodeling, it may also induce extremes on the walls of the coronary sinus, particularly at the distal and proximal ends of the generally flat and generally rigid elongated body 184. Stress concentration will occur in these places (see arrow P in Figure 7). To this end, the configuration of the generally flat and generally rigid elongated body 184 can be modified to better distribute these stresses.

更具体地说,接下来参看图17,大致平直且大致刚性的细长本体184的远端和近端可包括相对柔性的部分188A,190A,其有助于施加在冠状窦的壁上的应力更好地分布。作为附加和/或另选,应用于大致平直且大致刚性的细长本体184的远端和近端上的任何锥体可以是细长的,如图18中的标号188B,190B所示,从而使所施加的应力更好地分布在冠状窦的壁上。在本发明的一种优选形式中,现在参见图19,该大致平直且大致刚性的细长本体184包括具有相对细长锥体188B,190B的相对较长且相对柔性的部分188A,190A。如果需要的话,各个包括相对细长锥体188B,190B的相对较长且相对柔性的部分188A,190A可与细长本体184的大致平直且大致刚性的中间部分一样长,或者更长一些。More specifically, referring next to FIG. 17 , the distal and proximal ends of the generally flat and generally rigid elongated body 184 may include relatively flexible portions 188A, 190A that facilitate the application of pressure on the wall of the coronary sinus. Stress is better distributed. Additionally and/or alternatively, any tapers applied to the distal and proximal ends of the generally straight and generally rigid elongated body 184 may be elongated, as shown at 188B, 190B in FIG. The applied stress is thereby better distributed on the wall of the coronary sinus. In a preferred form of the invention, referring now to FIG. 19, the generally flat and generally rigid elongated body 184 includes a relatively long and relatively flexible portion 188A, 190A having a relatively elongated taper 188B, 190B. The relatively long and relatively flexible portions 188A, 190A, each including the relatively elongated cones 188B, 190B, may be as long as the generally straight and generally rigid mid-section of the elongated body 184, or longer, if desired.

在先前的讨论中,细长本体157(或184)通常描述成是大致平直且大致刚性的,带有或不带有相对柔性的部分175(图12)(或188A,190A,图17)和/或锥体178(图13)(或188B,190B,图18)和/或伸长的相对柔性的锥体部分175,178(图14)(188A,188B,190A,190B,图19)。然而应当理解,用语“大致平直”、“大致刚性”、“相对柔性”等应在涉及解剖组织的上下文中进行理解,而不应在绝对意义上进行理解。In the previous discussion, the elongated body 157 (or 184) was generally described as being generally flat and generally rigid, with or without a relatively flexible portion 175 (FIG. 12) (or 188A, 190A, FIG. 17) and/or cone 178 (FIG. 13) (or 188B, 190B, FIG. 18) and/or elongate relatively flexible cone portion 175, 178 (FIG. 14) (188A, 188B, 190A, 190B, FIG. 19) . It should be understood, however, that the terms "substantially straight", "substantially rigid", "relatively flexible" etc. are to be read in the context of referring to anatomy and not in an absolute sense.

大体上说,细长本体157(或184)构造成使得(1)其中间部分在冠状窦的壁上施加了向前的作用力(例如图7中的箭头A所示),以及(2)其远端和近端在冠状窦的壁上施加了向后的作用力(例如图7中的箭头P所示)。相反,通过二尖瓣环体在细长本体157(或184)的中间部分上施加了较高的中心载荷L1(图20),而冠状窦的后部部分在细长本体157(或184)的远端和近端上施加较小的末端载荷L2(图20)。In general, the elongated body 157 (or 184) is configured such that (1) its middle portion exerts an anterior force on the wall of the coronary sinus (eg, as indicated by arrow A in FIG. 7), and (2) Its distal and proximal ends exert a posterior force on the wall of the coronary sinus (eg, indicated by arrow P in Figure 7). In contrast, a higher central load L1 ( FIG. 20 ) is exerted by the mitral annulus on the middle portion of the elongated body 157 (or 184 ), while the posterior portion of the coronary sinus is on the elongated body 157 ( or 184 ). A small end load L2 is applied on the distal and proximal ends of , (Fig. 20).

通过使用细长本体157(或184)尤其可以产生这种影响,其中,(1)与二尖瓣环体的后部小叶附近的冠状窦部分的固有曲率相比,细长本体157(或184)更平直(但不必完全平直),(2)与由所配置的细长本体157(或184)移动的解剖组织相比,细长本体157(或184)更具刚性(但不必为完全刚性)。This effect can be produced in particular by using the elongated body 157 (or 184), wherein (1) the elongated body 157 (or 184 ) is straighter (but not necessarily perfectly straight), (2) the elongated body 157 (or 184) is more rigid (but not necessarily straight) than the anatomy moved by the configured elongated body 157 (or 184) completely rigid).

如上所述,为了使载荷更好地分布在冠状窦的近端部分上,细长本体157(或184)的远端和近端具有相对柔性的部分175(图12)(或188A,190A,图17)和/或锥体178(图13)(或188B,190B,图18)和/或细长的相对柔性的锥体部分175,178(图14)(188A,188B,190A,190B,图19)。此外,这些部分175(188A,190A),178(188B,190B)和/或175,178(188A,188B,190A,190B)的柔性可沿其长度而变化;因而,细长的相对柔性的锥体部分175,178(图14)(188A,188B,190A,190B,图19)随着其朝向其外端延伸而变得更具柔性。As noted above, the distal and proximal ends of the elongated body 157 (or 184) have relatively flexible portions 175 (FIG. 12) (or 188A, 190A, Fig. 17) and/or cone 178 (Fig. 13) (or 188B, 190B, Fig. 18) and/or elongated relatively flexible cone portion 175, 178 (Fig. 14) (188A, 188B, 190A, 190B, Figure 19). Additionally, the flexibility of these portions 175 (188A, 190A), 178 (188B, 190B) and/or 175, 178 (188A, 188B, 190A, 190B) may vary along their length; Body portions 175, 178 (FIG. 14) (188A, 188B, 190A, 190B, FIG. 19) become more flexible as they extend toward their outer ends.

的确,在本发明中并不要求细长本体157(或184)的中间部分是绝对刚性的;实际上,只要其基本上对二尖瓣环体所施加的较高中心载荷L1(图20)有一定抗性,即可起到令人满意的作用。通过使细长本体157(或184)的远端和近端对由冠状窦的后壁所引导的较小末端载荷L2(图20)形成较小的阻力,还可进一步改善设计。这样,利用一种沿着其长度具有刚度梯度的装置便可实现令人满意的设计,其中最高刚度位于或靠近中心,而较低刚度位于或靠近其两端(或者相反,该装置具有沿其长度的柔性梯度,其中最低柔性位于或靠近中心,而较高柔性位于或靠近其两端)。这可通过使细长本体逐渐变细;和/或通过改变其成分和/或材料属性;和/或通过本领域中的技术人员根据本公开而清楚的其它技术来实现。或者,可利用一种沿其整个长度具有一定程度的柔性的装置来实现令人满意的设计;这种柔性可随着长度而变化,或者沿细长本体157(或184)的整个长度都是大致恒定的。Indeed, it is not required in the present invention that the middle portion of the elongated body 157 (or 184) be absolutely rigid; in fact, as long as it substantially exerts a higher central load L1 on the mitral valve annulus (Fig. 20) With a certain resistance, it can play a satisfactory role. The design can be further improved by having the distal and proximal ends of the elongated body 157 (or 184) offer less resistance to the small end load L2 (Fig. 20) directed by the posterior wall of the coronary sinus. Thus, a satisfactory design can be achieved with a device that has a gradient of stiffness along its length, with the highest stiffness at or near the center and lower stiffness at or near its ends (or conversely, a device with stiffness along its length). A gradient of flexibility over length, with the lowest flexibility at or near the center and higher flexibility at or near its ends). This may be accomplished by tapering the elongated body; and/or by altering its composition and/or material properties; and/or by other techniques apparent to those skilled in the art from this disclosure. Alternatively, a satisfactory design can be achieved with a device that has some degree of flexibility along its entire length; roughly constant.

因此,如上所述,利用细长本体157(或184)可以实现令人满意的设计,其中,(1)与二尖瓣环体的后部小叶附近的冠状窦部分的固有曲率相比,细长本体157(或184)更平直(但不必完全平直),以及,(2)与由所配置的细长本体157(或184)移动的解剖组织相比,细长本体157(或184)更具刚性(但不必为完全刚性)。Thus, as described above, a satisfactory design can be achieved with an elongated body 157 (or 184) where (1) the elongated body 157 (or 184) is relatively thin compared to the inherent curvature of the coronary sinus portion near the posterior leaflet of the mitral annulus. The elongated body 157 (or 184) is straighter (but not necessarily perfectly straight), and (2) the elongated body 157 (or 184) is more straight than the anatomy that is moved by the configured elongated body 157 (or 184) ) is more rigid (but not necessarily perfectly rigid).

在其它备选的实施例中,细长本体157,184可由两个或多个大致平直且大致刚性的部分R组成,这些大致平直且大致刚性的部分R由一个或更多柔性部分F连接在一起。例如参见图21和22,其显示了这种构造。通过改变部分R和F的相对长度,并通过改变大致刚性部分R相对刚度和改变柔性部分F的相对柔性,便可实现良好的环体移动,从而更好地减少二尖瓣回流。In other alternative embodiments, the elongated body 157, 184 may be comprised of two or more generally flat and generally rigid portions R formed from one or more flexible portions F connected together. See, for example, Figures 21 and 22, which illustrate this configuration. By varying the relative lengths of portions R and F, and by varying the relative stiffness of the generally rigid portion R and varying the relative flexibility of the flexible portion F, good annulus movement and thus better mitral regurgitation reduction can be achieved.

图23和24显示了另一种优选构造,其中大致平直且大致刚性的细长本体157,184包括多个部分S1,S2和S3,其中部分S1构造成具有所选程度的柔性,部分S2构造成具有比部分S1更低程度的柔性,而部分S3构造成具有比部分S1更高程度的柔性。部分S1,S2和S3可相互形成一体,或者通过接头连接在一起。由于这种构造,部分S1将承载重构二尖瓣环体的载荷,部分S2将该载荷向外侧转移到部分S3,而部分S3将该载荷向外侧扩散到冠状窦的侧壁上。在本发明的一种优选形式中,部分S1构造成具有一定程度的柔性,这种柔性可支撑二尖瓣环体的重塑,同时允许部分S1在接合点处与二尖瓣环体的曲率弧线大致相符;部分S2构造成具有足够低程度的柔性,使得基本上所有由二尖瓣环体的重塑引起的载荷将被传递到部分S3上;并且部分S2具有足够长的长度,以便使作用在冠状窦的壁上的向后作用力(例如图7中的箭头P所示)基本上施加在瓣膜连合的近端和远端上。通过这种方式,纯粹拉直的作用产生向外的压力,其使心脏基底的纤维状连续部分张紧,而非在其中这种作用力会引起回流的瓣膜连合之间张紧。其中,这种构造成形成为使自身在后部小叶周围的区域中自然地对中,并且与后部小叶的曲率自然地相符。如果需要的话,这种“五区域式”的细长本体可由一种材料形成,其中利用不同的直径来形成不同的本体区域。Figures 23 and 24 show another preferred construction in which the generally flat and generally rigid elongated body 157, 184 comprises a plurality of sections S1 , S2 and S3 , wherein section S1 is configured to have a selected degree of Flexibility, section S2 is configured to have a lower degree of flexibility than section S1 , and section S3 is configured to have a higher degree of flexibility than section S1 . The sections S 1 , S 2 and S 3 can be integral with each other, or connected together by joints. Due to this configuration, section S1 will carry the load to remodel the mitral annulus, section S2 will transfer this load laterally to section S3 , and section S3 will spread this load laterally to the side wall of the coronary sinus superior. In a preferred form of the invention, portion S 1 is configured to have a degree of flexibility that supports remodeling of the mitral annulus while allowing portion S 1 to engage with the mitral annulus at the commissure point. roughly coincides with the arc of curvature; section S2 is configured to have a sufficiently low degree of flexibility that substantially all of the loads caused by the remodeling of the mitral annulus will be transferred to section S3 ; and section S2 has sufficient The length is long so that the backward force acting on the wall of the coronary sinus (eg, indicated by arrow P in FIG. 7 ) is substantially applied on the proximal and distal ends of the valve commissures. In this way, the pure straightening action creates outward pressure that tensions the fibrous continuum of the heart base, rather than between the valve commissures where such force would cause regurgitation. Therein, the configuration is shaped to center itself naturally in the region around the posterior leaflet and to naturally conform to the curvature of the posterior leaflet. If desired, such "five-region" elongated bodies may be formed from one material with different diameters used to form different body regions.

因此可以看到,在各种备选实施例中,细长本体157和/或184至少沿其一部分长度是柔性的。区域性的柔性和区域性的刚性可使冠状窦的所选位置变直,并且对应于后部二尖瓣环体的位置。这可导致二尖瓣环体的区域向前移动,从而在小叶接合中形成区域性改善。另外,细长本体可由细丝连接在一起的两个端部形成:通过相对于解剖结构来锚固这两个端部并拉紧细丝,可将冠状窦的自然弯曲的壁调直,以便使后部二尖瓣环体向前移动,从而减少二尖瓣回流。It can thus be seen that, in various alternative embodiments, elongated body 157 and/or 184 is flexible along at least a portion of its length. Regional flexibility and regional rigidity straighten selected locations of the coronary sinus and correspond to the location of the posterior mitral annulus. This can cause regions of the mitral annulus to move anteriorly, creating a regional improvement in leaflet coaptation. Alternatively, the elongated body can be formed by two ends of a filament joined together: by anchoring the two ends relative to the anatomy and tensioning the filament, the naturally curved walls of the coronary sinus can be straightened so that The posterior mitral annulus moves anteriorly, reducing mitral regurgitation.

通过改变细长本体157,184的刚性,可对二尖瓣带来一定范围的解剖结构上的变化。更具体地说,图25显示了小叶39,42充分接合的正常二尖瓣36,而图26显示了小叶39,42未充分接合的产生了回流的二尖瓣36。By varying the rigidity of the elongated bodies 157, 184, a range of anatomical changes can be brought about in the mitral valve. More specifically, Figure 25 shows a normal mitral valve 36 with adequate coaptation of the leaflets 39, 42, while Figure 26 shows a mitral valve 36 with insufficient coaptation of the leaflets 39, 42 producing regurgitation.

在细长本体157,184的中央部分相对于解剖结构而言较大且明显更具绝对刚性,并且细长本体157,184的两端终止于相对柔性的部分(例如图14和19所示的构造)的情况下,解剖结构的移动基本上如图27和28中所示。The central portion of the elongated body 157, 184 is relatively large and significantly more rigid relative to the anatomy, and the ends of the elongated body 157, 184 terminate in relatively flexible portions (eg, as shown in FIGS. 14 and 19 ). configuration), the movement of the anatomy is substantially as shown in FIGS. 27 and 28 .

在细长本体157,184具有在其中心S1和其两端S3处具有一定柔性而在连接部分S2处相对来说不可弯曲的杆件(例如图23和24中所示的结构)的情况下,可将其制成可提供用于支撑环体并与冠状窦的壁形成轻微接合的柔性吊带,例如图29和30所示。在本发明的一种优选形式中,细长本体157,184具有沿其长度定制的柔性,使其可与自然环体的几何形状紧密相符,以便使后部环体(以及后部小叶)朝向前部小叶移动,同时保持后部环体处于其固有曲率下,如图31和32中所示。The elongated body 157, 184 has a rod that is somewhat flexible at its center S1 and its ends S3 and relatively inflexible at its connecting portion S2 (such as the structure shown in FIGS. 23 and 24 ) In the case of an annulus, it can be made to provide a flexible sling for supporting the annulus and forming a light engagement with the wall of the coronary sinus, such as shown in FIGS. 29 and 30 . In a preferred form of the invention, the elongated body 157, 184 has tailored flexibility along its length to closely conform to the geometry of the natural annulus in order to orient the posterior annulus (and the posterior leaflets) toward The anterior leaflet moves while maintaining the posterior annulus in its natural curvature, as shown in FIGS. 31 and 32 .

在一种优选构造中,细长本体157,184具有定制的几何形状和柔性,使得作用在冠状窦的壁上的向后作用力(例如图7中箭头P所示)将分别主要应用于前、后连合的远端和近端的位置上。例如参见图30和32,其显示了所示构造如何将其作用力施加到病人的解剖结构上,即中间部分在冠状窦的壁上施加向前的作用力(如箭头A所示),而远端和近端在冠状窦的壁上施加向后的作用力(如箭头P所示)。通过将向后作用力P施加在瓣膜连合的区域中,就可最大限度地减少连合区域中的侧边喷射,并获得性能良好的小叶接合。In a preferred configuration, the elongated bodies 157, 184 have a tailored geometry and flexibility such that a rearward force acting on the wall of the coronary sinus (eg, indicated by arrow P in FIG. 7 ) will be applied primarily anteriorly, respectively. , The distal and proximal positions of the posterior commissure. See, for example, Figures 30 and 32, which show how the configuration shown applies its forces to the patient's anatomy, i.e. the medial portion exerts a forward force on the wall of the coronary sinus (as indicated by arrow A), while The distal and proximal ends exert a posterior force on the wall of the coronary sinus (arrow P). By applying a rearward force P in the area of the commissures of the valve, lateral jetting in the area of the commissures is minimized and good leaflet coaptation is achieved.

除前述之外,应当理解,作用于二尖瓣环体上的作用力总量是细长本体157,184的尺寸和几何形状以及其柔性的函数。在本发明的一种优选形式中,细长本体157,184的尺寸、几何形状和弹性优选使得有较高的作用力(如约2-5磅的作用力)施加在二尖瓣环体的中央部分上,由此当将细长本体157,184插入到冠状窦中时,通常将立刻实现基本上完全的二尖瓣重塑。在本发明的另一优选形式中,细长本体157,184的尺寸、几何形状和弹性优选使得有明显更小的作用力(如约1-3磅的压力)施加在二尖瓣环体上,由此当将细长本体157,184插入到冠状窦中时,通常将只立刻实现部分的二尖瓣重塑;然而,通过由足够柔性或优选超弹性的材料如镍钛合金形成细长本体157,184,那么即使在解剖结构响应于载荷而开始动作的情况下,细长本体也将之后持续对二尖瓣环体施加重塑作用力,从而逐渐实现所需的完全重塑。In addition to the foregoing, it should be understood that the amount of force acting on the mitral annulus is a function of the size and geometry of the elongated bodies 157, 184 and their flexibility. In a preferred form of the invention, the size, geometry and elasticity of the elongate body 157, 184 are preferably such that a relatively high force (such as about 2-5 pounds of force) is applied to the center of the mitral valve annulus. In part, thus when the elongate body 157, 184 is inserted into the coronary sinus, substantially complete remodeling of the mitral valve will generally be achieved immediately. In another preferred form of the invention, the size, geometry, and elasticity of the elongate bodies 157, 184 are preferably such that significantly less force (such as about 1-3 pounds of pressure) is exerted on the mitral valve annulus, Thus when the elongated bodies 157, 184 are inserted into the coronary sinus, only partial mitral valve remodeling will normally be achieved immediately; 157, 184, the elongated body will then continue to apply a remodeling force to the mitral annulus even as the anatomy begins to move in response to the load, gradually achieving the desired full remodeling.

在细长本体157,184由弹性材料形成并且所需的二尖瓣重塑将随时间逐步实现的后一种情况下,经常需要使细长本体157,184所施加的作用力随时间保持相对恒定。为此,某些材料可能会比其它材料更好。更具体地说,接下来参见图33,其显示了用于两种材料即镍钛合金和不锈钢的作用力变形曲线的示意图。如图33所示,当镍钛合金在最初植入期间发生变形然后在随后的组织重塑期间弛豫时,其对组织施加了相对恒定的作用力;然而,当不锈钢变形然后弛豫时,其对组织施加了变化很大的作用力。因此,细长本体157,184通常需要至少部分地由镍钛合金或其它超弹性的材料形成。In the latter case where the elongated bodies 157, 184 are formed of a resilient material and the desired mitral valve remodeling will be achieved over time, it is often desirable to keep the forces exerted by the elongated bodies 157, 184 relative over time. constant. For this, some materials may be better than others. More specifically, referring next to Fig. 33, a schematic diagram of force-deformation curves for two materials, Nitinol and stainless steel, is shown. As shown in Figure 33, when Nitinol deforms during initial implantation and then relaxes during subsequent tissue remodeling, it exerts a relatively constant force on the tissue; however, when stainless steel deforms and then relaxes, It exerts widely varying forces on tissues. Therefore, the elongated bodies 157, 184 generally need to be formed at least in part from Nitinol or other superelastic material.

除前述以外,细长本体157和/或184可具有各种沿其长度为非平直的形状。例如,细长本体可以是波浪形、螺旋形、或沿其整个或部分长度为弯曲的形状。作为示例,细长本体157和/或184可具有一种能够转换冠状窦的固有曲率的弯曲结构,即,使其朝向前部环体弯曲。或者,细长本体具有沿其长度的复合形状,例如,其可具有一种“w”形状,其中“w”的中心指向前部环体。任何这些或其它备选形状都可实现后部环体的向前移动,这便导致了二尖瓣回流的减少。In addition to the foregoing, elongated bodies 157 and/or 184 may have various shapes that are not straight along their length. For example, the elongated body may be undulating, helical, or curved along all or part of its length. As an example, elongate body 157 and/or 184 may have a curved configuration capable of translating the inherent curvature of the coronary sinus, ie, bending it toward the anterior annulus. Alternatively, the elongate body has a compound shape along its length, for example it may have a "w" shape with the center of the "w" pointing towards the anterior annulus. Any of these or other alternative shapes can achieve forward movement of the posterior annulus, which results in a reduction in mitral valve regurgitation.

接下来参见图34-36,可以看到,细长本体157和/或184设有从细长本体157,184径向向外延伸的环形肋200(图34和35)。肋200与输送导管106的壁相接合,或者在不使用输送导管106或已经取出输送导管106的情况下与冠状窦30的壁相接合,以便减轻细长本体157,184随时间的位移。肋200还由细长本体157,184中的环形凹槽202(图36)限定,在这种情况下,肋200的周向面204与本体周向面205重合。肋200设有大致平直的周边206(图34和36)或大致截头锥形结构的周边207(图35)。在后一种情况下,优选某些肋200的边缘207的斜面208朝向近端方向,而其余肋的斜面208朝向远端方向(图35)。在细长本体157,184包括柔性部分175(图12)(或188A,190A,图17)和/或锥体178(图13)或(188B,190B,图18)和/或细长的相对柔性的锥体部分175,178(图14)(或188A,188B,190A,190B,图19)的情况下,也可在这些结构上形成肋200。Referring next to Figures 34-36, it can be seen that the elongate body 157 and/or 184 is provided with an annular rib 200 extending radially outwardly from the elongate body 157, 184 (Figures 34 and 35). The ribs 200 engage the walls of the delivery catheter 106, or the walls of the coronary sinus 30 if the delivery catheter 106 is not in use or has been removed, to mitigate displacement of the elongate bodies 157, 184 over time. The rib 200 is also defined by an annular groove 202 ( FIG. 36 ) in the elongate body 157 , 184 , in which case the circumferential face 204 of the rib 200 coincides with the body circumferential face 205 . The rib 200 is provided with a generally flat perimeter 206 (Figs. 34 and 36) or a perimeter 207 of generally frusto-conical configuration (Fig. 35). In the latter case, it is preferred that the bevels 208 of the edges 207 of some ribs 200 face in the proximal direction, while the bevels 208 of the remaining ribs face in the distal direction (Fig. 35). The elongated body 157, 184 includes a flexible portion 175 (FIG. 12) (or 188A, 190A, FIG. 17) and/or a cone 178 (FIG. 13) or (188B, 190B, FIG. 18) and/or an elongated relative In the case of flexible tapered portions 175, 178 (Fig. 14) (or 188A, 188B, 190A, 190B, Fig. 19), ribs 200 may also be formed on these structures.

在图37中显示了结合图34中所示细长本体157,184来一起使用稳定支架210的备选实施例。在该实施例中,稳定支架210包括放置在与之相接合的冠状窦中的大致圆柱形梁架,并且牢固地锚固在冠状窦的壁上,之后将细长本体157,184(和其上的肋200)放在稳定支架210中。细长本体157,184的肋200与稳定支架210的一些部分相接合,使得细长本体牢固地锚固在冠状窦30中的合适位置上。例如,在稳定支架210包括处于其框架梁之间的开孔的情况下,肋200可与框架梁和开孔相互作用,以便帮助将细长本体157,184锁定在稳定支架210上。An alternative embodiment for use with a stabilizing bracket 210 in combination with the elongate bodies 157, 184 shown in FIG. 34 is shown in FIG. In this embodiment, the stabilizing stent 210 comprises a generally cylindrical beam that is placed in the coronary sinus it engages with and is firmly anchored to the wall of the coronary sinus, after which the elongated bodies 157, 184 (and The ribs 200) are placed in the stabilizing bracket 210. The ribs 200 of the elongated bodies 157 , 184 engage portions of the stabilizing bracket 210 such that the elongated bodies are securely anchored in place in the coronary sinus 30 . For example, where stabilizing bracket 210 includes openings between its frame beams, ribs 200 may interact with the frame beams and openings to help lock elongated bodies 157 , 184 to stabilizing bracket 210 .

更具体地说,利用本发明的这种形式,可将稳定支架210牢固地锚固在冠状窦的壁上(例如通过向外膨胀,和/或通过渗透到支架孔中的组织,和/或通过支架所携带的倒钩等),并且将细长本体157,184(与其上的肋200)牢固地锚固在稳定支架210上(例如通过肋-支架的接合),从而(1)帮助固定细长本体157,184以免纵向移动,以便提供可维持的二尖瓣回流减少,和/或(2)帮助在最大载荷L1(图20)作用于冠状窦的点处支撑冠状窦30,和/或(3)帮助将细长本体157,184的集中末端载荷L2(图20)分布在冠状窦的较大区域上,以便最大限度地减小对宿主血管造成的损伤,和/或(4)有助于限制血管断面响应于作用在血管内面上的载荷而发生的形态变化,以便保证可靠的血液流动并最大限度地减小血管损伤。在这方面应当理解,冠状窦沿其长度通常具有不同的特征(例如,直径、壁的坚固性等),并且可相应地将稳定支架210设计成沿其自身长度呈现出不同的特征。作为一个非限制性的示例,稳定支架210可具在其远端处具有较小的直径而在其近端处具有较大的直径,以便对应于冠状窦的典型几何形状。作为另一非限制性的示例,可将稳定支架210设计成在冠状窦的近端(此处静脉总是相对较软)处提供较大的支撑,而在冠状窦的远端(此处静脉总是相对较坚固)处提供较少的支撑。More specifically, with this form of the invention, the stabilizing stent 210 can be firmly anchored to the wall of the coronary sinus (e.g., by expanding outward, and/or by penetrating into the tissue in the stent hole, and/or by barbs, etc. carried by the stent), and securely anchors the elongated body 157, 184 (with the rib 200 thereon) to the stabilizing stent 210 (e.g., by rib-bracket engagement), thereby (1) helping to secure the Bodies 157, 184 are prevented from moving longitudinally so as to provide a sustained reduction in mitral valve regurgitation, and/or (2) help support coronary sinus 30 at the point where maximum load L1 ( FIG. 20 ) acts on the coronary sinus, and/or ( 3) help distribute the concentrated end load L2 (FIG. 20) of the elongated body 157, 184 over a larger area of the coronary sinus so as to minimize damage to the host vessel, and/or (4) help It is used to limit the morphological changes of the vascular section in response to the load acting on the inner surface of the blood vessel, so as to ensure reliable blood flow and minimize vascular damage. It should be appreciated in this regard that the coronary sinus typically has different characteristics (eg, diameter, wall firmness, etc.) along its length, and that the stabilizing scaffold 210 can be accordingly designed to exhibit different characteristics along its length. As a non-limiting example, the stabilizing stent 210 may have a smaller diameter at its distal end and a larger diameter at its proximal end so as to correspond to the typical geometry of the coronary sinus. As another non-limiting example, the stabilizing stent 210 can be designed to provide greater support at the proximal end of the coronary sinus (where the veins are always relatively soft) and at the distal end of the coronary sinus (where the veins are relatively soft). always relatively strong) provide less support.

在细长本体157放置在冠状窦30中的稳定支架210内的本发明的一种形式中,如上文所述,首先将导线103推进到冠状窦中。将具有稳定支架210的支架配置用导管212(图38)沿导线103推进到冠状窦中。当稳定支架210处于冠状窦中的所需位置时,跨置在导线103上的缓冲器214与稳定支架相接合,并且将支架配置用导管212拉回到足以配置稳定支架210的程度,之后随缓冲器214一起撤除,留下稳定支架210和导线103处于冠状窦30中的合适位置上。然后沿导线103传递输送导管106,直到导管的远端处在冠状窦和稳定支架中为止。一旦将输送导管106定位在冠状窦和稳定支架中,就可去除导线103。然后经由输送导管106的中央腔管136来传递推杆109,直到细长本体157定位在二尖瓣36的后部环体附近并位于稳定支架210中为止。然后撤回输送导管106,使得本体的肋200与稳定支架相接合,如上所述,推杆109留在合适的位置,并且细长本体157锁定在稳定支架210中。In one form of the invention in which the elongate body 157 is placed within the stabilizing stent 210 in the coronary sinus 30, the lead 103 is first advanced into the coronary sinus as described above. A stent deployment catheter 212 ( FIG. 38 ) with a stabilizing stent 210 is advanced along the guidewire 103 into the coronary sinus. When the stabilizing stent 210 is in the desired position in the coronary sinus, the bumper 214 straddling the guide wire 103 engages the stabilizing stent and the stent deployment catheter 212 is pulled back enough to deploy the stabilizing stent 210, followed by The bumpers 214 are removed together, leaving the stabilizing brace 210 and guidewire 103 in place in the coronary sinus 30 . The delivery catheter 106 is then passed along the guide wire 103 until the distal end of the catheter is in the coronary sinus and the stabilizing stent. Once the delivery catheter 106 is positioned in the coronary sinus and the stabilizing stent, the guide wire 103 can be removed. The pushrod 109 is then passed through the central lumen 136 of the delivery catheter 106 until the elongated body 157 is positioned near the posterior annulus of the mitral valve 36 and in the stabilizing bracket 210 . The delivery catheter 106 is then withdrawn so that the ribs 200 of the body engage the stabilizing bracket, the pushrod 109 is left in place and the elongated body 157 is locked in the stabilizing bracket 210 as described above.

在其中细长本体184放在冠状窦中的稳定支架210内的本发明的另一形式中,如上文所述地将导线103推入到冠状窦中。在其内带有稳定支架210的支架配置用导管212安装在导线103上,并推进到冠状窦30中。之后利用缓冲器214将稳定支架210保持在合适位置,并将支架配置用导管212拉回到足以配置稳定支架210的程度,之后将其随缓冲器214一并撤回,而将导线103和稳定支架210留在合适位置。然后在导线103上推动本体184和推压套管187,直到细长本体184设置在稳定支架210中为止。之后将推压套管187和导线103一并撤回,而将细长本体184和稳定支架210留在合适位置,并将细长本体184锁定在稳定支架中。In another form of the invention in which the elongated body 184 is placed within a stabilizing stent 210 in the coronary sinus, the lead 103 is advanced into the coronary sinus as described above. A stent deployment catheter 212 with a stabilizing stent 210 therein is mounted over the guide wire 103 and advanced into the coronary sinus 30 . The stabilizer 210 is then held in place by the buffer 214, and the stent deployment catheter 212 is pulled back enough to deploy the stabilizer 210, which is then withdrawn along with the buffer 214, leaving the lead 103 and the stabilizer 210 stays in place. Body 184 and push sleeve 187 are then pushed over lead 103 until elongated body 184 is disposed in stabilizing bracket 210 . The push sleeve 187 and guide wire 103 are then withdrawn together, leaving the elongated body 184 and stabilizing bracket 210 in place and locking the elongated body 184 in the stabilizing bracket.

参见图39,可以看到,作用在细长本体157,184和稳定支架210上的最大载荷(L1)位于其中间部分处,这便减小了稳定支架的位移,并因此减小了本体157,184向远端或近端的位移。Referring to Fig. 39, it can be seen that the maximum load (L1) acting on the elongated bodies 157, 184 and the stabilizing bracket 210 is located at the middle portion thereof, which reduces the displacement of the stabilizing bracket and thus the body 157 , 184 to the distal or proximal displacement.

接下来参见图40和41,还可以看到,细长本体157,184可具有比稳定支架210的直径明显更小的直径。在这种情况下,稳定支架210可设有用于接受细长本体157,184的导轨211。作为示例,导轨211包括形成于稳定支架210内壁上的空心管,导轨211的尺寸适合于接受细长本体157,184,并将其相对于稳定支架210进行固定。如果需要的话,稳定支架210可短于细长本体157,184的末端而终止,例如图40,41中所示。作为备选,稳定支架210与细长本体157,184的末端同步终止,例如以图42和43中的所示方式,或者,稳定支架210可延伸到细长本体157,184的末端之外,例如以图44和45中所示的方式。Referring next to FIGS. 40 and 41 , it can also be seen that the elongated bodies 157 , 184 may have a diameter that is significantly smaller than the diameter of the stabilizing bracket 210 . In this case, the stabilizing bracket 210 may be provided with rails 211 for receiving the elongated bodies 157,184. By way of example, rail 211 comprises a hollow tube formed on the inner wall of stabilizing bracket 210 , and rail 211 is sized to receive elongate body 157 , 184 and secure it relative to stabilizing bracket 210 . If desired, the stabilizing bracket 210 may terminate shorter than the ends of the elongated bodies 157, 184, such as shown in Figs. 40, 41 . Alternatively, the stabilizing bracket 210 terminates synchronously with the ends of the elongated bodies 157, 184, such as in the manner shown in FIGS. For example in the manner shown in FIGS. 44 and 45 .

在一种使用图40,41或图42,43或图44,45的稳定支架210和细长本体157,184的优选方法中,首先利用支架配置用导管212和缓冲器214来配置稳定支架210,这与图38相似,不同之处在于将导线103修改成偏心的,以便以图46所示方式延伸穿过稳定支架的导轨211。稳定支架210首先以上述方式进行配置,并使用导线103来将细长本体157,184装入到冠状窦中的合适位置,包括穿过稳定支架的导轨211。In a preferred method of using the stabilizing bracket 210 and the elongated body 157, 184 of FIGS. , which is similar to FIG. 38, except that the wire 103 is modified to be eccentric so as to extend through the guide rail 211 of the stabilizing bracket in the manner shown in FIG. 46. The stabilizing brace 210 is first configured in the manner described above, and the guide wire 103 is used to load the elongated bodies 157, 184 into place in the coronary sinus, including the rails 211 passing through the stabilizing brace.

现在参看图47,在另一构造中,当将稳定支架装入到支架配置用导管212中时,可将细长本体157,184预装入稳定支架的导轨211中;利用这种构造,可在冠状窦中同时配置稳定支架210和细长本体157,184。Referring now to FIG. 47, in another configuration, the elongated bodies 157, 184 may be preloaded into the rails 211 of the stabilizing bracket when the stabilizing bracket is loaded into the bracket deployment guide 212; Both the stabilizing brace 210 and the elongated bodies 157, 184 are deployed in the coronary sinus.

如图48所示,细长本体157,184可成形为稳定支架210的一部分,该组合的稳定支架部分位于细长本体157,184的中间部分处,在这里冠状窦施加了最大的载荷L1,它是因治疗而移动的冠状窦的载荷。同样,稳定支架210可短于细长本体157,184末端而终止(图48),或者稳定支架210可与细长本体157,184末端同步地终止(图49),或者稳定支架210延伸到细长本体157,184的末端之外(图50)。As shown in FIG. 48, the elongated bodies 157, 184 may be formed as part of a stabilizing bracket 210, the combined stabilizing bracket portion being located at the mid-portion of the elongated bodies 157, 184 where the coronary sinus applies the greatest load L1, It is the load on the coronary sinus that is displaced by the treatment. Likewise, the stabilizing bracket 210 may terminate shorter than the ends of the elongated bodies 157, 184 (Fig. 48), or the stabilizing bracket 210 may terminate synchronously with the ends of the elongated bodies 157, 184 (Fig. beyond the ends of the long bodies 157, 184 (Fig. 50).

在图51和52所示的另一实施例中,细长本体157,184和稳定支架210的组合包括两个或更多个支架部分,例如部分210A和210B,其中部分210A设置在该组合的中间部分,而部分210B延伸穿过部分210A并从其末端中伸出来,限定了具有更大弹性的末端部分。本体157,184固定在位于本体157,184的中间部分内的大致圆柱形支架部分210A上,并固定在半圆柱形的支架末端部分210B上。中间部分210A是细长本体和稳定支架的组合中最坚固的部分,它是用来承载最大载荷L1的那一部分。In another embodiment shown in FIGS. 51 and 52 , the combination of elongated body 157, 184 and stabilizing bracket 210 includes two or more bracket sections, such as sections 210A and 210B, wherein section 210A is disposed at the end of the combination. The middle portion, while portion 210B extends through portion 210A and protrudes from the end thereof, defines a more resilient end portion. The bodies 157, 184 are secured to a generally cylindrical frame portion 210A located in the middle portion of the bodies 157, 184, and to a semi-cylindrical frame end portion 210B. The middle part 210A is the strongest part of the combination of the elongated body and the stabilizing bracket, and it is the part used to carry the largest load L1.

在图53和54中显示了一个备选实施例,其中在细长本体157,184上固定有一组两行肋形式的肋215。如图54所示,肋215的行优选彼此偏离,使得位于细长本体157,184一侧上的肋并不与细长本体另一侧上的肋相对。这可使肋215朝向相对侧弯曲而不会与相对的肋接合。肋的弯曲允许肋被压缩而布置在导管中。An alternative embodiment is shown in Figures 53 and 54 in which a set of ribs 215 in the form of two rows of ribs are secured to the elongated body 157,184. As shown in Figure 54, the rows of ribs 215 are preferably offset from one another such that ribs on one side of the elongated body 157, 184 are not opposite ribs on the other side of the elongated body. This allows the rib 215 to bend towards the opposite side without engaging the opposing rib. The bending of the ribs allows the ribs to be compressed for placement in the catheter.

在图55中显示了与图54相似的一个备选构造,然而其显示出肋215与脊状件216相连,该脊状件216是中空的,以便在其中接受细长本体157,184。An alternative configuration similar to that of Fig. 54 is shown in Fig. 55, however showing ribs 215 connected to spines 216 which are hollow to receive elongate bodies 157, 184 therein.

在图56中显示了细长本体和支架组件的备选组合,其中稳定支架210包括形式为与支架集成在一起的杆件的细长本体部分157,184。在图56所示的实施例中,至少一个本体部分157,184从组件的一端延伸到另一端,而另一个本体部分157,184只延伸到组件的中间部分。因此,组件的末端部分比其中间部分的刚性更差。An alternative combination of elongated body and bracket assembly is shown in Figure 56, where a stabilizing bracket 210 includes elongated body portions 157, 184 in the form of rods integral with the bracket. In the embodiment shown in Fig. 56, at least one body portion 157, 184 extends from one end of the assembly to the other, while the other body portion 157, 184 extends only to the middle of the assembly. Consequently, the end sections of the assembly are less rigid than their middle sections.

参见图57可以看到,本体157,184只包括稳定支架,例如可伸缩地设置的稳定支架210',210"和210

Figure 048215258_0
,这样,中间部分包括所有三个稳定支架210′,210"和210
Figure 048215258_1
,刚好位于中间部分外侧的部分包括稳定支架210"和210
Figure 048215258_2
,而末端部分只包括稳定支架210
Figure 048215258_3
。因此,本体157,184的中间部分对移动的抵抗性最大,而末端部分的抵抗性最小,稳定支架210"的区域产生比中间部分更少的阻力,但其阻力大于末端部分。Referring to Fig. 57, it can be seen that the bodies 157, 184 only include stabilizing brackets, such as telescopically arranged stabilizing brackets 210', 210" and 210
Figure 048215258_0
, so that the middle part includes all three stabilizing brackets 210', 210" and 210
Figure 048215258_1
, the portion just outside the middle portion includes stabilizing brackets 210" and 210
Figure 048215258_2
, while the end part only includes the stabilizing bracket 210
Figure 048215258_3
. Thus, the middle portion of the body 157, 184 is most resistant to movement and the end portions are least resistant, the region of the stabilizing bracket 210" creating less resistance than the middle portion, but greater resistance than the end portions.

接下来参见图58-60,图中显示了细长本体和支架组件的备选组合,其中细长本体包括图23和24所示的五区域式细长本体157,184,而支架包括三个支撑支架,每个均如图40-47所示,即,具有用于接受细长本体157,184的导轨211。更具体地说,该五区域式细长本体157,184包括多个部分S1,S2和S3,其中部分S1构造成具有所选程度的柔性,部分S2构造成具有比部分S1更低程度的柔性,而部分S3构造成具有比部分S1更高程度的柔性。由于这种构造,部分S1将承载重构二尖瓣环体的载荷,部分S2将该载荷向外侧转移到部分S3,而部分S3将该载荷向外侧扩散到冠状窦的侧壁上。在本发明的一种优选形式中,部分S1构造成具有一定程度的柔性,这种柔性可支撑二尖瓣环体的重塑,同时允许部分S1在接合点处与二尖瓣环体的曲率弧线大致相符;部分S2构造成具有足够低程度的柔性,使得基本上所有由二尖瓣环体的重塑引起的载荷将被传递到部分S3上;并且部分S2具有足够长的长度,以便使作用在冠状窦的壁上的向后作用力(例如图7中的箭头P所示)将施加在瓣膜连合的区域中。支撑支架210定位在冠状窦30中,使得一个支架210容纳了部分S1,一个支架210容纳了一个部分S2,还有一个支架210容纳了另一部分S3。细长本体157,184可与支撑支架210同时进行配置,或者在配置了支撑支架210之后进行配置。部分S3优选能够在支架导轨211上滑动,尤其当细长本体157,184设计成在较长时期内逐步实现组织重塑的情况下。其中,这种构造成形为可使其自身在后部小叶周围的区域中自然地对中,并与后部小叶的曲率良好地相符。如果需要的话,这种“五区域式”的细长本体可由一种材料形成,其中利用不同的直径来形成不同的本体区域。Referring next to Figures 58-60, alternative combinations of elongated body and bracket assemblies are shown, wherein the elongated body includes the five-region elongated body 157, 184 shown in Figures 23 and 24, and the bracket includes three The support brackets, each as shown in FIGS. 40-47 , have rails 211 for receiving the elongated bodies 157 , 184 . More specifically, the five-region elongated body 157, 184 includes a plurality of sections S 1 , S 2 and S 3 , wherein section S 1 is configured to have a selected degree of flexibility and section S 2 is configured to have a greater flexibility than section S . 1 to a lower degree of flexibility, while section S3 is configured to have a higher degree of flexibility than section S1 . Due to this configuration, section S1 will carry the load to remodel the mitral annulus, section S2 will transfer this load laterally to section S3 , and section S3 will spread this load laterally to the side wall of the coronary sinus superior. In a preferred form of the invention, portion S 1 is configured to have a degree of flexibility that supports remodeling of the mitral annulus while allowing portion S 1 to engage with the mitral annulus at the commissure point. roughly coincides with the arc of curvature; section S2 is configured to have a sufficiently low degree of flexibility that substantially all of the loads caused by the remodeling of the mitral annulus will be transferred to section S3 ; and section S2 has sufficient The length is long so that a backward force acting on the wall of the coronary sinus (eg, indicated by arrow P in FIG. 7 ) will be exerted in the area of the valve commissures. The supporting brackets 210 are positioned in the coronary sinus 30 such that one bracket 210 accommodates a portion S 1 , one bracket 210 accommodates a portion S 2 , and one bracket 210 accommodates another portion S 3 . The elongate bodies 157, 184 may be deployed at the same time as the support bracket 210, or after the support bracket 210 is deployed. Section S3 is preferably slidable on stent rail 211, especially if elongate body 157, 184 is designed to achieve gradual tissue remodeling over an extended period of time. Among other things, this configuration is shaped to center itself naturally in the region around the posterior leaflet and to conform well to the curvature of the posterior leaflet. If desired, such "five-region" elongated bodies may be formed from one material with different diameters used to form different body regions.

还应当理解,支架210具有伸展式结构,或具有如图53和54所示的肋状结构。It should also be understood that the bracket 210 has a stretched configuration, or a ribbed configuration as shown in FIGS. 53 and 54 .

接着参见图61-63,图中显示了一种细长本体和支架组件的组合,其类似于图58-60中所示,不同之处在于,导轨211在每个支架区域之间延伸,从而形成具有三个与冠状窦的壁相接合的区域的单个支架结构。Referring next to Figures 61-63, there is shown an elongated body and bracket assembly combination similar to that shown in Figures 58-60, except that rails 211 extend between each bracket region so A single stent structure is formed having three regions that engage the wall of the coronary sinus.

这样,可以提供不同的稳定支架结构以防止该大致平直且大致刚性的细长本体产生位移,还可提供各种本体和稳定支架的组合以类似地防止或减轻这种位移。As such, different stabilizing bracket configurations may be provided to prevent displacement of the generally flat and generally rigid elongated body, as well as various body and stabilizing bracket combinations may be provided to similarly prevent or mitigate such displacement.

应当理解,本发明决不限于此处所公开和/或在图中示出的这些具体构造,而是包括权利要求范围内的所有改型或等同构造。It should be understood that the present invention is in no way limited to the specific constructions disclosed herein and/or shown in the drawings, but includes all modifications or equivalent constructions within the scope of the claims.

Claims (21)

1. device that is used to reduce mitral incompetence comprises:
Body with far-end, near-end and mid portion; When said body configuration becomes near the coronary sinus said body is positioned at mitral rear portion lobule; Said far-end and near-end apply active force backward to the wall of coronary sinus; And said mid portion applies active force forward to the wall of coronary sinus, so that said mitral rear portion ring body is moved forward, engages thereby improve lobule;
Said body is included in the rod member that has flat construction under the unstress state; And the rigidity of said device is higher than the anatomical tissue that is between device and the Bicuspid valve; Make the layout of said device in coronary sinus that the rear portion ring body will be moved forward, and improve the lobule joint;
Said body comprises a central area, two zone lines and two perimeters; Wherein, Said two zone lines lay respectively between a said central area and said two perimeters; Said central area is constructed with the flexibility of selected degree, and said zone line is constructed with than the said central area flexibility of low degree more, and said perimeter is constructed with the flexibility than said central area higher degree.
2. device according to claim 1 is characterized in that said device also comprises the center rest that links to each other with said rod member.
3. device that is used to reduce mitral incompetence comprises:
Be suitable for being inserted into the roughly straight slender body near the coronary sinus of the mitral rear portion of patient lobule; The length of said roughly straight slender body customizes with respect near the intrinsic curvature of the coronary sinus the lobule of Bicuspid valve rear portion; Make when said roughly straight slender body is positioned in the coronary sinus; It will cause at least a portion coronary sinus near the lobule of mitral rear portion, to demonstrate roughly straight structure; So that increase the radius of curvature of Bicuspid valve ring body, it is moved forward, engage thereby improve lobule;
Said body is included in has the roughly rod member of flat construction under the unstress state; And the rigidity of said device is higher than the anatomical tissue that is between device and the Bicuspid valve; Make the layout of said device in coronary sinus that the rear portion ring body will be moved forward, and improve the lobule joint;
Said body comprises a central area, two zone lines and two perimeters; Wherein, Said two zone lines lay respectively between a said central area and said two perimeters; Said central area is constructed with the flexibility of selected degree, and said zone line is constructed with than the said central area flexibility of low degree more, and said perimeter is constructed with the flexibility than said central area higher degree.
4. device according to claim 3; It is characterized in that; Said roughly straight slender body is roughly straight before in being inserted into patient, and after in being inserted into patient because of and anatomical structure between passive type elastic interaction but general curved.
5. device according to claim 3 is characterized in that said device comprises the center rest that is connected on the said rod member.
6. device that is used to reduce mitral incompetence comprises:
Be suitable for being inserted into the roughly inflexible slender body near the coronary sinus of the mitral rear portion of patient lobule; Said roughly inflexible slender body is constructed with respect near the intrinsic curvature of the coronary sinus the lobule of Bicuspid valve rear portion; Make when said roughly inflexible slender body is positioned in the coronary sinus; It causes at least a portion coronary sinus near the lobule of mitral rear portion, to demonstrate various structure, so that the rear portion ring body is moved forward, engages thereby improve lobule;
Said body is included in has the roughly rod member of flat construction under the unstress state; And the rigidity of said device is higher than the anatomical tissue that is between device and the Bicuspid valve; Make the layout of said device in coronary sinus that the rear portion ring body is moved forward, and improve the lobule joint;
Said body comprises a central area, two zone lines and two perimeters; Wherein, Said two zone lines lay respectively between a said central area and said two perimeters; Said central area is constructed with the flexibility of selected degree, and said zone line is constructed with than the said central area flexibility of low degree more, and said perimeter is constructed with the flexibility than said central area higher degree.
7. device according to claim 6 is characterized in that the rigidity of said roughly inflexible slender body is higher than the anatomical tissue that is between device and the Bicuspid valve, but still is flexible.
8. device according to claim 6 is characterized in that said device comprises the center rest that is connected on the said rod member.
9. device that is used to reduce mitral incompetence comprises:
Be suitable for being inserted into the roughly straight and roughly inflexible slender body near the coronary sinus of the mitral rear portion of patient lobule; Said length roughly straight and roughly inflexible slender body customizes with respect near the intrinsic curvature of the coronary sinus the lobule of said Bicuspid valve rear portion; Make when said roughly straight and roughly inflexible slender body is positioned in the coronary sinus; It causes at least a portion coronary sinus near the lobule of mitral rear portion, to demonstrate roughly straight structure; So that increase the radius of curvature of Bicuspid valve ring body, it is moved forward, engage thereby improve lobule;
Said body is included in has the roughly rod member of flat construction under the unstress state; And the rigidity of said device is higher than the anatomical tissue that is between device and the Bicuspid valve; Make the layout of said device in coronary sinus that the rear portion ring body is moved forward, and improve the lobule joint;
Said body comprises a central area, two zone lines and two perimeters; Wherein, Said two zone lines lay respectively between a said central area and said two perimeters; Said central area is constructed with the flexibility of selected degree, and said zone line is constructed with than the said central area flexibility of low degree more, and said perimeter is constructed with the flexibility than said central area higher degree.
10. device according to claim 9 is characterized in that, said slender body is roughly straight in being inserted into patient before, and is general curved after in being inserted into patient.
11. device according to claim 9 is characterized in that, the rigidity of said roughly inflexible slender body is higher than the anatomical structure that is between device and the Bicuspid valve, but still is flexible.
12. device according to claim 9 is characterized in that, said device comprises the center rest that is connected on the said rod member.
13. device according to claim 9; It is characterized in that; Said device also comprises and is suitable for being positioned at the delivery conduit in patient's coronary sinus; Said delivery conduit is formed by flexible material, makes its structure that will roughly demonstrate coronary sinus, and said delivery conduit is suitable for accepting therein said straight and roughly inflexible slender body.
14. device according to claim 13; It is characterized in that; Said straight and roughly inflexible slender body is installed on the rod member; Said rod member is formed by flexible material, make said rod member will demonstrate the structure of coronary sinus, and the size of said rod member is adapted to be mounted within the said delivery conduit.
15. device according to claim 13 is characterized in that, said device also comprises the lead removed that is used for said delivery conduit is positioned at coronary sinus.
16. device according to claim 9; It is characterized in that; Said device also comprises the lead that is suitable for being positioned in the coronary sinus, and said lead is formed by flexible material, makes it will roughly demonstrate the structure of coronary sinus; And said straight and roughly inflexible slender body is a hollow, so that be enclosed within on the said lead.
17. device according to claim 9; It is characterized in that; Said far-end straight and roughly inflexible slender body and at least one in the near-end comprise flexible portion, are used for when said straight and roughly inflexible slender body is arranged on coronary sinus, alleviating the stress that is applied on the coronary sinus.
18. device according to claim 9; It is characterized in that; Said far-end straight and roughly inflexible slender body and in the near-end at least one are tapered, are used for when said straight and roughly inflexible slender body is arranged on coronary sinus, alleviating the stress that is applied on the coronary sinus.
19. device according to claim 9 is characterized in that, said straight and roughly inflexible slender body has the length that is no more than the coronary sinus part that is between coronary ostium and the AIV.
20. device according to claim 13 is characterized in that, said device also comprises supporting tube, is used for when said straight and roughly inflexible slender body passes said delivery conduit, preventing that said delivery conduit from redirecting to postcava.
21. a device that is used to reduce mitral incompetence comprises:
Be suitable for being inserted into the slender body near the coronary sinus of patient's Bicuspid valve rear portion lobule; Said device is suitable for transforming near the intrinsic curvature of at least a portion coronary sinus of Bicuspid valve rear portion lobule; So that said rear portion ring body is moved forward; Engage thereby improve lobule, wherein said device is included in rod member that has flat construction under the unstress state and the center rest that links to each other with said rod member;
Said body comprises a central area, two zone lines and two perimeters; Wherein, Said two zone lines lay respectively between a said central area and said two perimeters; Said central area is constructed with the flexibility of selected degree, and said zone line is constructed with than the said central area flexibility of low degree more, and said perimeter is constructed with the flexibility than said central area higher degree.
CN2004800215258A 2003-05-27 2004-05-26 Method and apparatus for improving mitral valve function Expired - Fee Related CN1829485B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/446,470 US7125420B2 (en) 2002-02-05 2003-05-27 Method and apparatus for improving mitral valve function
US10/446,470 2003-05-27
PCT/US2004/016472 WO2004105584A2 (en) 2003-05-27 2004-05-26 Method and apparatus for improving mitral valve function

Publications (2)

Publication Number Publication Date
CN1829485A CN1829485A (en) 2006-09-06
CN1829485B true CN1829485B (en) 2012-03-21

Family

ID=33489384

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2004800215258A Expired - Fee Related CN1829485B (en) 2003-05-27 2004-05-26 Method and apparatus for improving mitral valve function

Country Status (6)

Country Link
EP (1) EP1628599A4 (en)
JP (1) JP4456605B2 (en)
CN (1) CN1829485B (en)
AU (2) AU2004243029B2 (en)
CA (1) CA2526110A1 (en)
WO (1) WO2004105584A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440164B1 (en) 1999-10-21 2002-08-27 Scimed Life Systems, Inc. Implantable prosthetic valve
US6602286B1 (en) 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
US6752828B2 (en) 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
US7007698B2 (en) 2002-04-03 2006-03-07 Boston Scientific Corporation Body lumen closure
JP2006503654A (en) 2002-10-24 2006-02-02 ボストン サイエンティフィック リミテッド Venous valve device and method
US6945957B2 (en) 2002-12-30 2005-09-20 Scimed Life Systems, Inc. Valve treatment catheter and methods
US7854761B2 (en) 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7566343B2 (en) 2004-09-02 2009-07-28 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
CA2588653A1 (en) * 2004-11-24 2006-06-01 Viacor, Inc. Method and apparatus for improving mitral valve function
US20060173490A1 (en) 2005-02-01 2006-08-03 Boston Scientific Scimed, Inc. Filter system and method
US7867274B2 (en) 2005-02-23 2011-01-11 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7722666B2 (en) 2005-04-15 2010-05-25 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US8012198B2 (en) 2005-06-10 2011-09-06 Boston Scientific Scimed, Inc. Venous valve, system, and method
US7569071B2 (en) 2005-09-21 2009-08-04 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US8133270B2 (en) 2007-01-08 2012-03-13 California Institute Of Technology In-situ formation of a valve
EP2109417B1 (en) 2007-02-05 2013-11-06 Boston Scientific Limited Percutaneous valve and delivery system
US7892276B2 (en) 2007-12-21 2011-02-22 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
EP2967945B1 (en) 2013-03-15 2020-10-28 California Institute of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
EP2805695A1 (en) * 2013-05-21 2014-11-26 Medtentia International Ltd Oy Medical system for annuloplasty
IT202000012562A1 (en) 2020-05-27 2021-11-27 Milano Politecnico DEVICE AND ASSEMBLY FOR REPAIRING A HEART VALVE
EP4572684A1 (en) 2022-08-16 2025-06-25 Boston Scientific Scimed, Inc. Medical device for occluding a left atrial appendage
US12171662B1 (en) 2023-10-26 2024-12-24 Approxima Srl Heart chamber reshaping and valve repair system

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US6524301B1 (en) * 2000-12-21 2003-02-25 Advanced Cardiovascular Systems, Inc. Guidewire with an intermediate variable stiffness section

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5911732A (en) * 1997-03-10 1999-06-15 Johnson & Johnson Interventional Systems, Co. Articulated expandable intraluminal stent
SE514718C2 (en) * 1999-06-29 2001-04-09 Jan Otto Solem Apparatus for treating defective closure of the mitral valve apparatus
US7186264B2 (en) * 2001-03-29 2007-03-06 Viacor, Inc. Method and apparatus for improving mitral valve function
JP2004533294A (en) * 2001-04-27 2004-11-04 マイオメンド,インコーポレーテッド Prevention of myocardial infarction induced ventricular dilation and remodeling
US6797001B2 (en) * 2002-03-11 2004-09-28 Cardiac Dimensions, Inc. Device, assembly and method for mitral valve repair

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US6524301B1 (en) * 2000-12-21 2003-02-25 Advanced Cardiovascular Systems, Inc. Guidewire with an intermediate variable stiffness section

Also Published As

Publication number Publication date
CN1829485A (en) 2006-09-06
WO2004105584A3 (en) 2005-05-26
CA2526110A1 (en) 2004-12-09
JP4456605B2 (en) 2010-04-28
EP1628599A4 (en) 2011-12-28
AU2004243029A1 (en) 2004-12-09
EP1628599A2 (en) 2006-03-01
WO2004105584A2 (en) 2004-12-09
AU2004243029B2 (en) 2009-12-03
AU2010200752A1 (en) 2010-03-18
JP2007503287A (en) 2007-02-22

Similar Documents

Publication Publication Date Title
CN1829485B (en) Method and apparatus for improving mitral valve function
US7125420B2 (en) Method and apparatus for improving mitral valve function
JP4184794B2 (en) Method and apparatus for improving mitral valve function
US7186264B2 (en) Method and apparatus for improving mitral valve function
US7052487B2 (en) Method and apparatus for reducing mitral regurgitation
AU2004258950B2 (en) Method and apparatus for improving mitral valve function
US7608102B2 (en) Focused compression mitral valve device and method
US20030078654A1 (en) Method and apparatus for improving mitral valve function
AU2002240288A1 (en) Method and apparatus for improving mitral valve function
CN101443073B (en) Method and apparatus for improving mitral valve function
EP1383448A2 (en) Method and apparatus for improving mitral valve function
JP2004535851A (en) BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention generally relates to techniques for treating mitral dysfunction, such as mitral valve leakage. More specifically, the present invention relates to systems and methods for treating leaky mitral valves in a minimally invasive manner.
AU2006203499B2 (en) Method and apparatus for improving mitral valve function

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120321

Termination date: 20130526